60 results on '"Romano N"'
Search Results
2. [Professor Mariano R. Castex on his golden wedding anniversary with medicine].
- Author
-
ROMANO N
- Subjects
- History, 19th Century, History, 20th Century, Anniversaries and Special Events, Medicine
- Published
- 1958
3. Monitoring of toxicities induced by Chimeric Antigen Receptor T-cell therapy: Protocol for a phenomenological study on the experiences of nurses
- Author
-
Valentina Simonetti, Letizia Governatori, Francesco Galli, Cesare Tozzi, Romano Natalini, Andrea Toccaceli, Francesco Pastore, Giancarlo Cicolini, and Dania Comparcini
- Subjects
hematology ,nursing ,car-t therapy ,phenomenological ,qualitative ,Medicine ,Nursing ,RT1-120 - Abstract
Introduction: Chimeric Antigen Receptor T-cell therapy (CAR-T) represents the most recent immunotherapy’s innovation to cure some refractory and/or relapsing haematological tumours. However, because of the life-threatening toxicities it might cause such as Cytokine Release Syndrome and Immune Cell Associated Neurotoxicity Syndrome, patients are closely monitored by nurses for the early identification of toxicities during the post-infusion phase of CAR-T cell therapy. Exploring the nurses’ experience with respect to any difficulties related to the monitoring is important since these issues can be perceived by patients and affect the nurse-patient’s caring relationship, considered as a shared lived experience between the patient and the nurse. Aim: This study aims to investigate haematology nurses’ lived experience with monitoring CAR-T’s induced toxicities. Materials and methods: A qualitative study following Cohen's phenomenological methodology will be conducted through semi-structured interviews in a sample of Italian nurses working in haematology units, who have had previous experience in the management of patients undergoing CAR-T therapy for at least two months and who have performed the monitoring for the same months of experience; the interviews will be audio-recorded and then transcribed verbatim. Two researchers will carry out the manual analysis and interpretation of the collected data independently, identifying themes and sub-themes. Conclusion: To explore the nurses’ experiences in this field could facilitate the identification of the educational needs, at individual and group level. Despite it is important to consider contextual variables, the findings of this study could contribute to develop evidence supporting advanced and specialized nursing care in the haematological setting.
- Published
- 2024
- Full Text
- View/download PDF
4. Study on intestinal parasitic infections and gut microbiota in cancer patients at a tertiary teaching hospital in Malaysia
- Author
-
Sidi Omar Siti Farah Norasyikeen, Romano Ngui, Ab Rahman Syaza Zafirah, Muhammad Zarul Hanifah Md Zoqratt, Wilhelm Wei Han Eng, Qasim Ayub, Syafinaz Amin Nordin, Vesudian Narcisse Mary Sither Joseph, Sabri Musa, and Yvonne Ai Lian Lim
- Subjects
Medicine ,Science - Abstract
Abstract Intestinal parasitic infections (IPIs) can lead to significant morbidity and mortality in cancer patients. While they are unlikely to cause severe disease and are self-limiting in healthy individuals, cancer patients are especially susceptible to opportunistic parasitic infections. The gut microbiota plays a crucial role in various aspects of health, including immune regulation and metabolic processes. Parasites occupy the same environment as bacteria in the gut. Recent research suggests intestinal parasites can disrupt the normal balance of the gut microbiota. However, there is limited understanding of this co-infection dynamic among cancer patients in Malaysia. A study was conducted to determine the prevalence and relationship between intestinal parasites and gut microbiota composition in cancer patients. Stool samples from 134 cancer patients undergoing active treatment or newly diagnosed were collected and examined for the presence of intestinal parasites and gut microbiota composition. The study also involved 17 healthy individuals for comparison and control. Sequencing with 16S RNA at the V3–V4 region was used to determine the gut microbial composition between infected and non-infected cancer patients and healthy control subjects. The overall prevalence of IPIs among cancer patients was found to be 32.8%. Microsporidia spp. Accounted for the highest percentage at 20.1%, followed by Entamoeba spp. (3.7%), Cryptosporidium spp. (3.0%), Cyclospora spp. (2.2%), and Ascaris lumbricoides (0.8%). None of the health control subjects tested positive for intestinal parasites. The sequencing data analysis revealed that the gut microbiota diversity and composition were significantly different in cancer patients than in healthy controls (p
- Published
- 2024
- Full Text
- View/download PDF
5. High HIV-1 diversity in immigrants resident in Italy (2008–2017)
- Author
-
Maggiorella M. T., Sanarico N., Brindicci G., Monno L., Santoro C. R., Coppola N., Cuomo N., Azzurri A., Cesario F., Luciani F., El-Hamad I., D'Ettorre G., Turriziani O., Mazzuti L., Poggi A., Vichi F., Mariabelli E., Surace L., Berardelli G., Picconi O., Cenci A., Sernicola L., Rovetto C., Fulgenzi D., Belli R., Salvi E., Zeo P. D., Borsetti A., Ridolfi B., Losappio R., Zoboli F., Schietroma I., Cella E., Angeletti S., Ciccozzi M., D'Amato S., Ensoli B., Butto S., Angarano G., Babudieri S., Scheri G. C., Lichtner M., Martini S., Mazzella A., Romano N., Pansera A., Pontali E., Raddi A., Starnini G., Dell'Isola S., Maggiorella, M. T., Sanarico, N., Brindicci, G., Monno, L., Santoro, C. R., Coppola, N., Cuomo, N., Azzurri, A., Cesario, F., Luciani, F., El-Hamad, I., D'Ettorre, G., Turriziani, O., Mazzuti, L., Poggi, A., Vichi, F., Mariabelli, E., Surace, L., Berardelli, G., Picconi, O., Cenci, A., Sernicola, L., Rovetto, C., Fulgenzi, D., Belli, R., Salvi, E., Zeo, P. D., Borsetti, A., Ridolfi, B., Losappio, R., Zoboli, F., Schietroma, I., Cella, E., Angeletti, S., Ciccozzi, M., D'Amato, S., Ensoli, B., Butto, S., Angarano, G., Babudieri, S., Scheri, G. C., Lichtner, M., Martini, S., Mazzella, A., Romano, N., Pansera, A., Pontali, E., Raddi, A., Starnini, G., and Dell'Isola, S.
- Subjects
0301 basic medicine ,Male ,Latin Americans ,Immigration ,Human immunodeficiency virus (HIV) ,lcsh:Medicine ,HIV Infections ,Drug resistance ,medicine.disease_cause ,Antiretroviral Therapy, Highly Active ,Cluster Analysis ,HIV Infection ,lcsh:Science ,Phylogeny ,media_common ,Recombination, Genetic ,Multidisciplinary ,Geography ,virus diseases ,High HIV-1 diversity in immigrants ,Middle Aged ,Italy ,Medicine ,Infectious diseases ,Female ,Human ,Adult ,Tuberculosis ,media_common.quotation_subject ,Science ,030106 microbiology ,Emigrants and Immigrants ,Article ,03 medical and health sciences ,Population screening ,Drug Resistance, Viral ,medicine ,Humans ,Hepatitis ,Cluster Analysi ,lcsh:R ,Genetic Variation ,Emigrants and Immigrant ,medicine.disease ,Antiretroviral therapy ,030104 developmental biology ,Mutation ,HIV-1 ,lcsh:Q ,Demography ,Diversity (politics) - Abstract
The proportion of new diagnoses of HIV infection in immigrants residing in Italy raised from 11% in 1992 to 29.7% in 2018. To investigate the HIV clades circulating in this community a retrospective study was performed in 557 HIV-infected immigrants living in 12 Italian cities. Immigrants originated from East-Europe and Central-Asia (11.7%), North Africa and Middle East (7.3%), South and South-East Asia (7.2%), Latin America and the Caribbean (14.4%), and sub-Saharan Africa (59.4%). More than 87% of immigrants were on antiretroviral therapy (ART), although 26.6% of them were viremic. A 22.0% of immigrants had hepatitis (HBV and/or HCV) and/or tuberculosis. HIV phylogenetic analysis on sequences from 192 immigrants showed the presence of clades B (23.4%), G (16.1%), C (10.4%), A1 (9.4%), F1 (5.2%), D (1.6%) and Circulating Recombinant Forms (CRFs) (33.9%). CRF02_AG represented 72.3% of the total CRFs. Clusters between immigrants and Italian natives were also present. Drug resistance mutations to NRTI, NNRTI, and PI drug classes occurred in 29.1% of ART-treated and in 12.9% of ART-naïve individuals. These data highlight the need for tailored public health interventions in immigrants to avoid spreading in Italy of HIV genetic forms and ART-resistant variants, as well as HIV co-morbidities.
- Published
- 2020
6. Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients
- Author
-
Ungaro, R., Taramasso, L., Bruzzone, B., Vicenti, I., Galli, L., Borghi, V., Francisci, D., Pecorari, M., Zoncada, A., Callegaro, A. P., Paolini, E., Monno, L., Bonora, S., Di Biagio, A., ARCA Study Group, Giacometti, A., Butini, L., del Gobbo, R., Bagnarelli, P., Tacconi, D., Corbelli, G., Zanussi, S., Punzi, G., Maggiolo, F., Calza, L., Carla Re, M., Pristera, R., Turconi, P., Mandas, A., Tini, S., Amadio, G., Sighinolfi, L., Corsi, P., Di Pietro, M., Colao, G., Tosti, A., Setti, M., Cenderello, G., Trezzi, M., Orani, A., Arcidiacono, I., Degiuli, A., De Gennaro, M., Chiodera, A., Scalzini, A., Palvarini, L., Todaro, G., Rusconi, S., Gismondo, M. R., Micheli, V., Biondi, M. L., Capetti, A., Meraviglia, P., Boeri, E., Mussini, C., Soria, A., Vecchi, L., Santirocchi, M., Brustia, D., Ravanini, P., Dal Bello, F., Romano, N., Mancuso, S., Calzetti, C., Maserati, R., Filice, G., Baldanti, F., Parruti, G., Polilli, E., Sacchini, D., Martinelli, C., Consolini, R., Vatteroni, L., Vivarelli, A., Nerli, A., Lenzi, L., Magnani, G., Ortolani, P., Andreoni, M., Fimiani, C., Palmisano, L., Di Giambenedetto, S., Vullo, V., Turriziani, O., Montano, M., Antinori, A., Zaccarelli, M., Dentone, C., Gonnelli, A., De Luca, A., Palumbo, M., Ghisetti, V., Delle Foglie, P., Rossi, C., Mondino, V., Malena, M., Grossi, P., Seminari, E., Poletti, F., Ungaro R., Taramasso L., Bruzzone B., Vicenti I., Galli L., Borghi V., Francisci D., Pecorari M., Zoncada A., Callegaro A.P., Paolini E., Monno L., Bonora S., Di Biagio A., Giacometti A., Butini L., del Gobbo R., Bagnarelli P., Tacconi D., Corbelli G., Zanussi S., Punzi G., Maggiolo F., Calza L., Carla Re M., Pristera R., Turconi P., Mandas A., Tini S., Amadio G., Sighinolfi L., Corsi P., Di Pietro M., Colao G., Tosti A., Setti M., Cenderello G., Trezzi M., Orani A., Arcidiacono I., Degiuli A., De Gennaro M., Chiodera A., Scalzini A., Palvarini L., Todaro G., Rusconi S., Gismondo M.R., Micheli V., Biondi M.L., Capetti A., Meraviglia P., Boeri E., Mussini C., Soria A., Vecchi L., Santirocchi M., Brustia D., Ravanini P., Dal Bello F., Romano N., Mancuso S., Calzetti C., Maserati R., Filice G., Baldanti F., Parruti G., Polilli E., Sacchini D., Martinelli C., Consolini R., Vatteroni L., Vivarelli A., Nerli A., Lenzi L., Magnani G., Ortolani P., Andreoni M., Fimiani C., Palmisano L., Di Giambenedetto S., Vullo V., Turriziani O., Montano M., Antinori A., Zaccarelli M., Dentone C., Gonnelli A., De Luca A., Palumbo M., Ghisetti V., Delle Foglie P., Rossi C., Mondino V., Malena M., Grossi P., Seminari E., and Poletti F.
- Subjects
Male ,antiretroviral treatment ,Infectious Disease Transmission ,genotype ,Human immunodeficiency virus (HIV) ,Drug Resistance ,HIV Infections ,Drug resistance ,medicine.disease_cause ,Retrospective Studie ,Genotype ,pol Gene Products, Human Immunodeficiency Viru ,Prevalence ,Medicine ,Vertical ,HIV Infection ,Viral ,pol Gene Products ,Young adult ,General Medicine ,Infectious Diseases ,Italy ,Mutation (genetic algorithm) ,Female ,Human Immunodeficiency Virus ,Human ,Microbiology (medical) ,Adult ,Settore MED/17 - Malattie Infettive ,Adolescent ,Anti-HIV Agents ,Young Adult ,Acquired resistance ,Drug Resistance, Viral ,Humans ,vertical HIV transmission ,HIV-1 ,Mutation ,Retrospective Studies ,pol Gene Products, Human Immunodeficiency Virus ,Infectious Disease Transmission, Vertical ,HIV perinatally infection ,business.industry ,Anti-HIV Agent ,Retrospective cohort study ,Virology ,Large cohort ,business - Published
- 2019
7. General anaesthetic and airway management practice for obstetric surgery in England: a prospective, multicentre observational study
- Author
-
Odor, P. M., Bampoe, S., Moonesinghe, S. R., Andrade, J., Pandit, J. J., Lucas, D. N., A’Court, A., Abdel-Gadir, D., Abdu, A., Abisogun, C., Aboud, Z., Abrams, J., Ackerman, A., Adamson, C., Addison, R., Adeyeye, A., Adler, R., Aduse-Poku, M., Adyanthaya, S., Ahmad, N., Ahmed, D., Ahmed, A., Akindele, B., Akindele, O., Akrimi, S., Al-Rawi, S., Ali, Y., Allam, J., Allana, A., Allen, K., Allen, O., Amaradasa, N., Amarasekara, L., Amoakwa-adu, F., Anandageetha, P., Anandakrishnan, S., Anandanadesan, R., Anderson, M., Apps, S., Aquilina, A., Arbane, G., Arch, A., Armstrong, S., Arya, R., Ashiru, G., Ashpole, K., Atkinson, C., Atkinson, F., Auer, E., Avery, B., Babio-Galan, M., Bader, H., Badham, G., Bagchi, S., Bailey, S., Baird, Y., Balaka, C., Baldwin, M., Balfour, P., Bali, S., Banks, S., Barclay, P., Barnes, L., Barnes, T., Barot, N., Barrett, S., Barrett, V., Barrett, K., Bates, L., Batte, K., Baytug, B., Behravesh, M., Bell, S., Benloch, R., Bentley, R., Berg, J., Berwick, C., Berwick, R., Bhadange, R., Bhattacharyya, S., Bielskute, E., Birch, S., Bird, S., Bird, Ruth, Birts, William, Black, Becky, Blagova, Tatyana, Blake, Holly, Blightman, Oliver, Blunden, Susara, Bolton, R., Borkett-Jones, C., Boselli, J., Bowen, M., Bowen, R., Bowyer, J., Boyle, H., Brar, Z., Bray, J., Brayshaw, S., Bressington, C., Brewer, A., Brice, N., Bridge, L., Briscoe, J., Brocklesby, S., Brown, H., Brown, S., Brunnen, D., Burijintichenna, K., Burnard, S., Burtt, A., Buswell, V., Bykar, H., Cairney, M., Calvert, C., Camarasa, L., Campbell, N., Campbell-Jones, F., Cantliffe, J., Carrol, W., Carvalho, J., Cashell, C., Cassie, S., Cassim, K., Chandler, M., Chapman, R., Charles, R., Chen, P., Cheyne, D., Chima, K., Chin, F., Chirvasuta, R., Shao Chong, M., Choudhury, S., Chowdhury, P., Christmas, T., Chughwani, S., Ciechanowicz, S., Clarey, E., Coe, R., Cohen, J., Coker, N., Collins, K., Collis, L., Comar, J., Conroy, M., Constantin, K., Corfe, J., Coulborn, E., Cowie, V., Crone, R., Cronin, J., Crooks, J., Crowther, N., Crowther, E., Cruz, C., Curtis, A., Curtis, S., Dabrowicz, A., Daines, N., Dalal, V., Dannatt, P., Das, D., Dash, J., Davidson, K., Davies, S., Davis, Y., Dawson, J., Dean, J., Dean, C., Denman, J., Desai, N., Dewan, P., Dimont, S., Donovan, C., Doraiswami, M., Doughty, K., Douglass, J., Dower, M., Downing, S., Duberry, W., Duckham, E., Dudgeon, L., Dukes, S., Dunn, L., Duraiswamy, V., Dwyer, A. O., Dyer, K., Eapen, S., Earl, M., Eason, S., Edwards, K., Edwards, Z., Egole, O., Ekpa, J., el-Amin, O., el-Boghdadly, K., Elbasir, O., Eldridge, J., Elgie, L., Ellington, M., Elliott, K., Elliott, J., Elmi, M., Elnoumeir, R., Emeakaraoha, E., Evans, M., Everett, M., Fabb, P., Farooq, H., Farrimond, R., Faulds, F., Fawcett, E., Feneley, A., Fernando, D., Ferns, J., Finlay, C., Fitzgerald, S., O’Flaherty, D., Fleet, M., Fletcher, L., Fludder, V., Follet, T., Forbes, J., Forth, M., Foster, G., Francis, J., Fraser, K., Friedman, L., Fruggeri, L., Fulton, L., Funnell, S., Gadre, A., Gandhi, A., Gardiner, H., Garner, Z., Garvey, G., Gately, T., George, R., Gillespie, S., Glover, S., Goddard, J., Goodman, B., Gopal, T., Graham, G., Green, D., Griffin, D., Griffith, J., Grigsby, S., Grindey, J., Griffiths, H., Groome, J., Grother, C., Grounds, G., Groves, A., Guha, A., Gunawardhana, A., Gupta, A., Gupta, R., Gutsell, J., Haddon, R., Hadi, D., Hadjipavlou, N., Hammerbeck, H., Hammon, L., Hammond, S., Hampanna, H., Hancock, H., Handapangoda, H., Haroon-Mowahed, Y., Harpham, D., Harris, G., Harrison, A., Harshan, D., Hartopp, A., Harty, E., Haslam, N., Hawkins, G., Hawkins, E., Hawksey, S., Hays, C., Hazelton, T., Heavyside, A., Hemeson, C., Henderson, K., Henry, O., Herbert, L., Higgins, N., Hilton, J., Hindmoor, C., Hitchcock, R., Hobbs, L., Homsy, M., Honeywell, C., Hoque, N., House, K., Howle, R., Tiller, A., Huniak, M., Hunte, J., Husain, T., Huson, C., Hussain, C., Hussain, T., Hussein, Z., Hyams, J., Hyde, E., Laverdino, M., Ignacka, A., Innes, E., Ioannidis, S., Iqbal, R., Ismail, F., Jackson, J., Jackson, M., Jackson, G., Jacobs, R., Jadhav, P., Jalaly, A., James, L., James, M., Jani, S., Jeganathan, C., Joannides, C., Johnson, R., Johnson, T., Johnston, C., Jones, R., Jones, T., Kadr, M., Kainth, R., Kane, J., Kanji, R., Kannanparambil, S., Kar, G., Kasianandan, T., Kaskos, H., Kavanagh, L., Kaye, R., Kelliher, L., Kelliot, S., Kelly, J., Kenyon, C., Kessack, L., Kestner, S., Khaku, M., Khaleeq, S., Khan, P., Khan, S., Kidwai, U., King, C., King, H., Kingston, E., Kok, W., Konig, R., Konstantinova, Z., Krishnan, P., Kua, J., Kuntumalla, K., Kursumovic, E., Kurzatkowski, K., Kuttambakam, H., Lane, K., Lane, S., Langton, A., Latif, H., Lau, N., Laxman, S., Laycock, H., Lee, R., Leonardi, S., Light, K., Lightfoot, H., Liu, S., Liyanage, S., Lowe, J., Lucas, N., Lungu, M., Lunn, M., Lynes, H., Machavarapu, K., Mackenzie, M., Magee, D., Major, J., Male, V., Malik, Z., Manso, K., Maquinana, M., Marciniak, K., Maronge, L., Marsh, C., Martella, C., Martin, N., Martins, N., Marway, J., Mason, L., Masood, N., Masters, J., Maton-Howarth, M., Mazzola, F., McAllister, T., McCarthy, R., McCormick, C., McCready, S., McDougall, S., Mcewan, L., McGarry, J., McKevitt, H., Mckinley, S., Mckskeane, A., McMaster, E., McMonagle, M., McNamara, H., McPhee, H., McRae, L., Mead, D., Meadows, E., Mehta, M., Meikle, J., Metodiev, Y., Michael, C., Millar, V., Miller, S., Miller, G., Milne, S., Miltsios, K., Misquita, L., Misquita, S., Mittal, M., Mohamed, M., Powell Monaghan, K., Monk, J., Monkhouse, A., Monks, D., Montague, L., Moon, A., Moran, J., Moreton, A., Morgan, E., Morgan, O., Morland, D., Morosan, M., Morris, K., Morris, A., Moser, C., Mount, M., Muir, C., Mupudzi, M., Murali, M., Murdoch, I., Murray, H., Murray, T., Murrell, K., Narasimha Murthy, G., Neeley, D., Nei, H., Neil, K., Nejim, T., Nel, M., Nicholson, A., Nicklin, A., Nolan, C., Nolan, T., Nurmi, E., O’Neill, B., Oakes, C., Oakes, N., Ochoa-Ferraro, M., Odeleye, N., Oliver, K., Oliver, M., Onslow, J., Onwochei, D., Oommen, T., Orr, T., Osagie, O., Osborn, H., Overend, J., Owston, H., Pack, E., Padhi, P., Palani, P., Pandey, R., Pandya, D., Panesar, N., Papageorgiou, C., Papanastasiou, G., Papoutsos, C., Pararajasingham, S., Parry, J., Patel, H., Patel, J., Patel, K., Patel, M., Patel, R., Patel, N., Pathak, S., Pearson, F., Peciulene, V., Peers, B., Peirce, B., Pepper, S., Perinpanayagam, J., Perry, H., Petrova, N., Phillips, T., Phillips, S., Phylactides, L., Pilkington, F., Plumb, J., Poimenidi, E., Sau Kuk Poon, A., Potter, T., Poultney, U., Powell, L., Prenter, A., Preston, K., Price, A., Pritchard, N., Pullen, J., Purohit, M., Quamina, C., Qureshi, J., Rajput, Z., Ramage, S., Ramanathan, T., Ranasinghe, U., Ranatunga, K., Rand, A., Randive, S., Rangarajan, D., Rao, C., Rao Pelluri, S., Ratnasingham, A., Razzaque, J., Reddy, A., Redington, K., Reel, E., Remeta, P., Ricco, F., Riccoboni, A., Rice, P., Rich, M., Richards, N., Riches, J., Ripoll, S., Roberts, F., Roberts, K., Robins, K., Robinson, S., Roche, S., Rojo, M., Carmela Romano, N., Rosser, H., Roughley, L., Routley, C., Rowley, C., Rudra, P., Russell, R., Ryan, C., Saad, C., Sadeghi, A., Salberg, A., Salota, V., Samuel, M., Samuels, R., Sanapala, S., Sanusi, S., Sarao, S., Sathyabhama, S., Saunders, Z., Sawarzynska-ryszka, B., Sceales, P., Schumacher, N., Schwartz, N., Sellers, C., Sellers, H., Sellick, J., Sen, S., Senaratne, D., Senbeto, S., Seneviratna, D., Setty, T., Shah, R., Shah, S., Shambly, J., Sharafudeen, S., Sharieff, I., Sharifi, L., Sharpe, L., Shaw, M., Sheldrake, I., Shinde, P., Shonfeld, A., Short, J., Siah, J., Sibug, S., Siddique, O., Siew, S., Simpson, M., Singleton, G., Sinha, K., Sinha, A., Sinnott, M., Sivadhas, H., Sivakumar, S., Sivarajan, B., Sivarajan, S., Skeoch, C., Slade, S., Slater, P., Smith, C., Smith, E., Smith, J., Smith, L., Smith, A., Smith, R., Smith, S., Smith, T., Smithers, H., Smolen, S., Smyth, C., Snel, T., Snipe, C., Soltanifar, S., Sonawane, N., Soundararaja, A., Spence, E., Spiliopoulos, M., Srivastava, C., Stacey, K., Stafford, H., Staines, N., Stead, R., Stevens, E., Stilwell, A., Stocks, G., Stokes, A., Stone, C., Straughan, B., Subbarathnam, V., Sudunagunta, S., Sultan, P., Suppiah, P., Surve, P., Sutherland, A., Swanton, R., Swarbrick, C., Swinson, A., Syrrakou, E., Tadbiri, S., Tamhane, P., Tamilselvan, P., Tan, A., Tanna, S., Tarft, H., Tarry, L., Taylor, I., Taylor, S., Tebbot, J., Theron, S., Thomas, M., Todd, S., Tolliday, H., Topham, C., Tovell, N., Traves, M., Trodd, D., Tufchi, A., Turley, K., Turnbull, M., Turnbull, C., Turner, O., Turner, W., Turney, S., Tyagi, E., Uncles, D., Unsworth, V., Vadnere, P., Varadan, R., Vasishta, V., Veal, A., Vedham, L., Venkaya, J., Verghese, M., Veronica, I., Vidanagamage, D., Vincent, R., Vyapury, V., Wain, H., Walbridge, F., Walker, E., Walsh, P., Walshe, E., Walters, M., Wan, Y., Wang, C., Wankhade, K., Waters, G., Watts, C., Webber, A., Wedgwood, T., Wee, M., Wellstead, S., White, A., Whitear, M., Whitefield, L., Wilkinson, S., Williams, L., Williams, R., Wilson, D., Wilson, S., Wimble, K., Winkley, E., Winslow, L., Winwright, P., Wloch, K., Wong, G., Wong, H., Man Wong, J., Wood, T., Wray, S., Wrench, I., Wu, J., Wynn, K., Yap, Y., Kuan Yeow, C., Young, E., Yusaf, A., Uz Zafar, S., Zeinali, D., Zhang, S., Zope, S., Zucco, L., Anwar, S., Blunt, N., Grover, V., Grailey, K., Gray, M., Highton, D., Hopkins, P., Kemp, H., Lo, Q., Martin, D., Morkane, C., O’Carroll, J., Oliver, C., Post, B., Visram, A., Wickham, A., General Paediatrics, Graduate School, Adult Psychiatry, and Pulmonology
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Population ,03 medical and health sciences ,0302 clinical medicine ,030202 anesthesiology ,medicine ,Caesarean section ,General anaesthesia ,general anaesthesia ,030212 general & internal medicine ,Rocuronium ,General anaesthetic ,education ,Neuromuscular Blockade ,education.field_of_study ,airway management ,obstetrics ,business.industry ,Tracheal intubation ,Surgery ,Anesthesiology and Pain Medicine ,caesarean section ,Airway management ,business ,medicine.drug - Abstract
There are no current descriptions of general anaesthesia characteristics for obstetric surgery, despite recent changes to patient baseline characteristics and airway management guidelines. This analysis of data from the direct reporting of awareness in maternity patients' (DREAMY) study of accidental awareness during obstetric anaesthesia aimed to describe practice for obstetric general anaesthesia in England and compare with earlier surveys and best-practice recommendations. Consenting patients who received general anaesthesia for obstetric surgery in 72 hospitals from May 2017 to August 2018 were included. Baseline characteristics, airway management, anaesthetic techniques and major complications were collected. Descriptive analysis, binary logistic regression modelling and comparisons with earlier data were conducted. Data were collected from 3117 procedures, including 2554 (81.9%) caesarean deliveries. Thiopental was the induction drug in 1649 (52.9%) patients, compared with propofol in 1419 (45.5%). Suxamethonium was the neuromuscular blocking drug for tracheal intubation in 2631 (86.1%), compared with rocuronium in 367 (11.8%). Difficult tracheal intubation was reported in 1 in 19 (95%CI 1 in 16-22) and failed intubation in 1 in 312 (95%CI 1 in 169-667). Obese patients were over-represented compared with national baselines and associated with difficult, but not failed intubation. There was more evidence of change in practice for induction drugs (increased use of propofol) than neuromuscular blocking drugs (suxamethonium remains the most popular). There was evidence of improvement in practice, with increased monitoring and reversal of neuromuscular blockade (although this remains suboptimal). Despite a high risk of difficult intubation in this population, videolaryngoscopy was rarely used (1.9%).
- Published
- 2020
8. Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe
- Author
-
De Luca, A, Dunn, D, Zazzi, M, Camacho, R, Torti, C, Fanti, I, Kaiser, R, Sönnerborg, A, Codoñer, Fm, Van Laethem, K, Vandamme, Am, Bansi, L, Ghisetti, V, van de Vijver DA, Asboe, D, Prosperi, Mc, Di Giambenedetto, S, Collaborators: Giacometti A, SEHERE collaboration in C. h. a. i. n., Butini, L, del Gobbo, R, Menzo, S, Tacconi, D, Corbelli, G, Zanussi, S, Monno, L, Punzi, G, Maggiolo, F, Callegaro, A, Calza, L, Pristerà, R, Turconi, P, Mandas, A, Tini, S, Zoncada, A, Paolini, E, Amadio, G, Sighinolfi, L, Zuccati, G, Morfini, M, Manetti, R, Corsi, P, Galli, L, Di Pietro, M, Bartalesi, F, Colao, G, Tosti, A, Di Biagio, A, Setti, M, Bruzzone, B, Penco, G, Trezzi, M, Orani, A, Pardelli, R, De Gennaro, M, Chiodera, A, Scalzini, A, Palvarini, L, Almi, P, Todaro, G, Monforte, Ad, Cicconi, P, Rusconi, S, Gismondo, Mr, Micheli, V, Biondi, Ml, Gianotti, N, Capetti, A, Meraviglia, P, Boeri, E, Mussini, C, Pecorari, M, Soria, A, Vecchi, L, Santirocchi, M, Brustia, D, Ravanini, P, Dal Bello, F, Romano, N, Mancuso, S, Calzetti, C, Maserati, R, Filice, G, Baldanti, F, Francisci, D, Parruti, G, Polilli, E, Sacchini, D, Martinelli, C, Consolini, Rita, De Luca, A, Dunn, D, Zazzi, M, Camacho, R, Torti, C, Fanti, I, Kaiser, R, Sönnerborg, A, Codoñer, F, Van Laethem, K, Vandamme, A, Bansi, L, Ghisetti, V, Van De Vijver, D, Asboe, D, Prosperi, M, Di Giambenedetto, S, Mancuso, S, and Virology
- Subjects
Male ,Multivariate analysis ,Databases, Factual ,Drug Resistance ,HIV Infections ,Drug resistance ,0302 clinical medicine ,Retrospective Studie ,Risk Factors ,Epidemiology ,Genotype ,pol Gene Products, Human Immunodeficiency Viru ,Odds Ratio ,Prevalence ,Immunology and Allergy ,HIV Infection ,030212 general & internal medicine ,pol Gene Products ,Viral ,Multivariate Analysi ,media_common ,0303 health sciences ,Drug Resistance Prevalence HIV-1 ,Middle Aged ,Resistance mutation ,3. Good health ,Reverse Transcriptase Inhibitor ,Europe ,Infectious Diseases ,Reverse Transcriptase Inhibitors ,epidemiology ,Female ,Multiple ,Human Immunodeficiency Virus ,Human ,Drug ,Adult ,medicine.medical_specialty ,Evolution ,media_common.quotation_subject ,Sexual Behavior ,antiretroviral therapy ,Infectious Disease ,Biology ,Settore MED/17 - MALATTIE INFETTIVE ,Evolution, Molecular ,03 medical and health sciences ,Databases ,SDG 3 - Good Health and Well-being ,Drug Resistance, Multiple, Viral ,medicine ,Humans ,HIV Protease Inhibitor ,Factual ,Retrospective Studies ,030306 microbiology ,Risk Factor ,Molecular ,Retrospective cohort study ,Odds ratio ,HIV Protease Inhibitors ,CD4 Lymphocyte Count ,drug resistance ,genotyping ,HIV-1 ,Multivariate Analysis ,Mutation ,pol Gene Products, Human Immunodeficiency Virus ,Immunology ,Demography - Abstract
HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in antiretroviral treatment (ART)-exposed individuals across 7 countries in Europe. Of 20 323 cases, 80% carried at least one resistance mutation: these declined from 81% in 1997 to 71% in 2008. Predicted extensive 3-class resistance was rare (3.2% considering the cumulative genotype) and peaked at 4.5% in 2005, decreasing thereafter. The proportion of cases exhausting available drug options dropped from 32% in 2000 to 1% in 2008. Reduced risk of resistance over calendar years was confirmed by multivariable analysis. © 2013 The Author.
- Published
- 2013
- Full Text
- View/download PDF
9. First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias
- Author
-
Stefanutti, C, D'Alessandri, G, Petta, A, Harada-Shiba, M, Julius, U, Soran, H, Moriarty, P. M, Romeo, S, Drogari, E, Jaeger, B. R, Bianciardi, G, Bosco, G, Cossu, M, De Fusco, G, Di Giacomo, S, Ewald, N, Gualdi, G, Lanti, A, Marson, P, Martino, F, Migliori, G, Parasassi, T, Pavan, A, Perla, F. M, Perrone, G, Pisciotta, L, Renga, S, Ries, W, and Romano, N
- Subjects
medicine.medical_specialty ,Time Factors ,International Cooperation ,Practice Patterns ,Coronary artery disease ,Dyslipidemia ,Lipoprotein apheresis ,Multicenter study ,Survey ,Biomarkers ,Blood Component Removal ,Cardiovascular Diseases ,Cooperative Behavior ,Dyslipidemias ,Guideline Adherence ,Health Care Surveys ,Humans ,Hypolipidemic Agents ,Lipids ,Molecular Diagnostic Techniques ,Practice Guidelines as Topic ,Practice Patterns, Physicians' ,Predictive Value of Tests ,Risk Factors ,Surveys and Questionnaires ,Treatment Outcome ,Internet ,Internal Medicine ,Cardiology and Cardiovascular Medicine ,Multidisciplinary approach ,medicine ,Parallel field ,Therapeutic apheresis ,Physicians' ,business.industry ,General Medicine ,medicine.disease ,Clinical trial ,Current practice ,Family medicine ,Physical therapy ,business - Abstract
The MightyMedic (Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast) Working Group has been founded in 2013. The leading idea was to establish an international network of interdisciplinary nature aimed at working to cross national borders research projects, clinical trials, educational initiatives (meetings, workshops, summer schools) in the field of metabolic diseases, namely hyperlipidemias, and diabetes, preventive cardiology, and atherosclerosis. Therapeutic apheresis, its indications and techniques, is a parallel field of investigation. The first on-line survey of the Group has been completed in the first half of 2014. The survey included # 24 Centers in Italy, Germany, Greece, UK, Sweden, Japan and USA. Relevant data have been collected on current practice in diagnosis, therapy and follow-up of dyslipidemias. 240 subjects with hyperlipidemia and treated with lipoprotein apheresis have been reported in the survey, but a large percentage of patients (35%) who could benefit from this therapeutic option are still treated by conventional drug approach. Genetic molecular diagnosis is performed in only 33% of patients while Lipoprotein(a) (Lp(a)) is included in cardiovascular disease risk assessment in 71% of participating Centers. New detailed investigations and prospective multicenter studies are needed to evaluate changes induced by the impact of updated indications and strategies, as well as new treatment options, targeting standardization of therapeutic and diagnostic approaches. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
- Published
- 2015
- Full Text
- View/download PDF
10. Genotypic and phenotypic characterization of Escherichia coli isolated from indigenous individuals in Malaysia
- Author
-
Vanitha Mariappan, Soo Tein Ngoi, Yvonne Ai Lian Lim, Romano Ngui, Kek Heng Chua, and Cindy Shuan Ju Teh
- Subjects
genotypic ,indigenous ,malaysia ,phenotypic ,verocytotoxin (vt)-producing escherichia coli (vtec) ,Medicine - Abstract
Objective(s): The occurrence of asymptomatic verocytotoxin (VT)-producing Escherichia coli (VTEC) infections among humans in recent years is posing a high risk to public health. Thus, the role of asymptomatic human carriers as a source of dissemination should not be underestimated. This study aimed to elucidate the phenotypic and genotypic characteristics of E. coli in the stool samples collected from indigenous individuals in Malaysia. Materials and Methods: E. coli strains (n=108) were isolated from stool samples obtained from 41 indigenous individuals. All strains were subjected to Repetitive Extragenic Palindromic-Polymerase Chain Reaction (REP-PCR) typing and confirmation of VTEC variants. Non-duplicate strains were selected based on REP-PCR profiles and further subjected to antimicrobial susceptibility test (AST). The genotypic and phenotypic characteristics of the strains were then correlated with the demographic data of the subjects. Results: A total of 66 REP-PCR profiles grouped in 53 clusters (F=85%) were obtained. Four genetically distinct strains were confirmed as VTEC (eaeA-positive). The predominant resistance was against ampicillin (34.2%), followed by trimethoprim-sulfamethoxazole (32.9%), ampicillin-sulbactam (5.5%), and ciprofloxacin (1.4%). All isolates were sensitive to amoxicillin-clavulanate, cefuroxime, ceftriaxone, imipenem, and meropenem. Conclusion: Genetically diverse E. coli and VTEC strains were found to colonize the intestines of the indigenous populations. This study is important for the prospective surveillance of E. coli among the indigenous individuals in Malaysia, especially in asymptomatic VTEC infection and antimicrobial resistance phenomenon.
- Published
- 2022
- Full Text
- View/download PDF
11. Tobacco use among medical students in Europe: results of a multicentre study using the Global Health Professions Student Survey
- Author
-
La Torre, G, Kirch, W, Bes Rastrollo, M, Ramos, Rm, Czaplicki, M, Gualano, MARIA ROSARIA, Thümmler, K, Ricciardi, W, Boccia, A, GHPSS Collaborative Group, Siliquini, Roberta, Manzoli, L, Firenze, A, Romano, N, Zscheppang, A, Valero Juan, L. F., La Torre, G., Kirch, W., Bes-Rastrollo, M., Ramos, R.M., Czaplicki, M., Gualano, M.R., Thümmler, K., Ricciardi, W., Boccia, A., Siliquini, R., Manzoli, L., Firenze, A., Romano, N., Zscheppang, A., and Valero Juan, L.F.
- Subjects
Gerontology ,Adult ,Male ,medicine.medical_specialty ,Medical psychology ,Students, Medical ,Cross-sectional study ,medicine.medical_treatment ,education ,Population ,MEDLINE ,Settore MED/42 - Igiene Generale E Applicata ,Young Adult ,europe ,medical students ,tobacco smoking ,Global health ,medicine ,Prevalence ,Humans ,Young adult ,Medical student ,education.field_of_study ,business.industry ,Smoking ,Public Health, Environmental and Occupational Health ,General Medicine ,Medical students ,Confidence interval ,Medical students, Tobacco smoking ,Tobacco smoking ,Europe ,Cross-Sectional Studies ,Family medicine ,Smoking cessation ,Female ,Smoking Cessation ,business ,Attitude to Health - Abstract
Objective: To examine smoking prevalence, knowledge and attitudes, and tobacco cessation training among university students attending European medical schools using the Global Health Professional Students Survey approach. Methods: A cross-country, cross-sectional study was performed among 12 medical schools in four countries in Europe (Germany, Italy, Poland and Spain). The survey was performed during the second semester of the third year of study from March to May 2009. Results: In total, 2249 subjects entered the study (overall response rate 92%). The overall prevalence of smoking among medical students was 29.3% (95% confidence interval 28.1-34.7), with percentages ranging from 28% in Germany to 31.3% in Italy. This study found that more than two-thirds of medical students believe that health professionals are role models for patients, with different beliefs in Poland (89.6%) and Germany (77.7%) vs Italy and Spain (57.2% and 54.4%, respectively) (P < 0.001). Smoking cessation training at medical school was only reported by 16.5% of students (lowest proportion in Italy, 3.5%) (P < 0.001). In terms of smoking cessation methods, the vast majority (89.8%) of medical students were aware of nicotine patches and gum (highest prevalence in Spain, 96.3%), and 24.4% were aware of the use of antidepressants (highest prevalence in Germany, 33.6%). Conclusion: This European survey found that the prevalence of smoking was higher among medical students than the general population. There is a strong need to provide medical students with training in smoking cessation techniques
- Published
- 2012
12. Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis
- Author
-
Sterrantino, G, Zaccarelli, M, Colao, G, Baldanti, F, Di Giambenedetto, S, Carli, T, Maggiolo, F, Zazzi, M, Giacometti, A, Butini, L, Del Gobbo, R, Bagnarelli, P, Tacconi, D, Corbelli, G, Zanussi, S, Monno, L, Punzi, G, Callegaro, A, Calza, L, Re, MC, Pristera, R, Turconi, P, Mandas, A, Tini, S, Zoncada, A, Paolini, E, Amadio, G, Sighinolfi, L, Zuccati, G, Morfini, M, Manetti, R, Corsi, P, Galli, L, Di Pietro, M, Bartalesi, F, Tosti, A, Di Biagio, A, Setti, M, Bruzzone, B, di Biagio, A, Penco, G, Trezzi, M, Orani, A, Pardelli, R, Arcidiacono, I, Degiuli, A, de Gennaro, M, Chiodera, A, Scalzini, A, Palvarini, L, Almi, P, Todaro, G, Cicconi, P, Rusconi, S, Gismondo, MR, Micheli, V, Biondi ML, Gianotti, N, Capetti, A, Meraviglia, P, Boeri, E, Mussini, C, Pecorari, M, Soria, A, Vecchi, L, Gerardo, AO, Santirocchi, M, Brustia, D, Maggiore, AO, Ravanini, P, Bello, FD, Romano, N, MANCUSO, Salvatrice, Calzetti, C, Maserati, R, Filice, G, Francisci, D, Parruti, G, Polilli, E, Sacchini, D, Martinelli, C, Consolini, R, Vatteroni, L, Vivarelli, A, Nerli, A, Lenzi, L, Magnani, G, Ortolani, P, Andreoni, M, Palamara, G, Fimiani, C, Palmisano, L, di Giambenedetto, S, Colafigli, M, Vullo, V, Turriziani, O, Montano, M, Antinori, A, Dentone, C, Gonnelli, A, de Luca, A, Palumbo, M, Ghisetti, V, Bonora, S, Foglie, PD, Rossi, C, Mondino, V, Malena, M, Grossi, P, Seminari, E, Poletti, F., Sterrantino, G, Zaccarelli, M, Colao, G, Baldanti, F, Di Giambenedetto, S, Carli, T, Maggiolo, F, Zazzi, M, Giacometti, A, Butini, L, Del Gobbo, R, Bagnarelli, P, Tacconi, D, Corbelli, G, Zanussi, S, Monno, L, Punzi, G, Callegaro, A, Calza, L, Re, MC, Pristera, R, Turconi, P, Mandas, A, Tini, S, Zoncada, A, Paolini, E, Amadio, G, Sighinolfi, L, Zuccati, G, Morfini, M, Manetti, R, Corsi, P, Galli, L, Di Pietro, M, Bartalesi, F, Tosti, A, Di Biagio, A, Setti, M, Bruzzone, B, di Biagio, A, Penco, G, Trezzi, M, Orani, A, Pardelli, R, Arcidiacono, I, Degiuli, A, de Gennaro, M, Chiodera, A, Scalzini, A, Palvarini, L, Almi, P, Todaro, G, Cicconi, P, Rusconi, S, Gismondo, MR, Micheli, V, Biondi ML, Gianotti, N, Capetti, A, Meraviglia, P, Boeri, E, Mussini, C, Pecorari, M, Soria, A, Vecchi, L, Gerardo, AO, Santirocchi, M, Brustia, D, Maggiore, AO, Ravanini, P, Bello, FD, Romano, N, Mancuso, S, Calzetti, C, Maserati, R, Filice, G, Francisci, D, Parruti, G, Polilli, E, Sacchini, D, Martinelli, C, Consolini, R, Vatteroni, L, Vivarelli, A, Nerli, A, Lenzi, L, Magnani, G, Ortolani, P, Andreoni, M, Palamara, G, Fimiani, C, Palmisano, L, di Giambenedetto, S, Colafigli, M, Vullo, V, Turriziani, O, Montano, M, Antinori, A, Dentone, C, Gonnelli, A, de Luca, A, Palumbo, M, Ghisetti, V, Bonora, S, Foglie, PD, Rossi, C, Mondino, V, Malena, M, Grossi, P, Seminari, E, and Poletti, F
- Subjects
Male ,Time Factors ,Cross-sectional study ,Human immunodeficiency virus (HIV) ,Drug Resistance ,HIV Infections ,Drug resistance ,medicine.disease_cause ,Cohort Studies ,Antiretroviral Therapy, Highly Active ,Ritonavir-boosted darunavir ,Genotype ,HIV Infection ,Treatment Failure ,Viral ,Genotypic resistance ,Darunavir ,Sulfonamides ,General Medicine ,Middle Aged ,Virological failure ,Infectious Diseases ,Female ,Human ,medicine.drug ,Adult ,Microbiology (medical) ,Logistic Model ,Time Factor ,Antiretroviral Therapy ,Settore MED/17 - MALATTIE INFETTIVE ,Sulfonamide ,Drug Resistance, Viral ,medicine ,Humans ,Highly Active ,Protease inhibitors ,Cross-Sectional Studies ,HIV Protease Inhibitors ,HIV-1 ,Logistic Models ,Mutation ,HIV Protease Inhibitor ,Cross-Sectional Studie ,business.industry ,Antiretroviral therapy ,Virology ,Protease inhibitor ,Cohort Studie ,business - Abstract
Introduction: This study aimed at defining protease (PR) resistance mutations associated with darunavir (DRV) failure and PR resistance evolution at DRV failure in a large database of treatment-experienced human immunodeficiency virus (HIV) patients. Results: Overall, 1,104 patients were included: 118 (10.7%) failed at a median observation time of 16 months. The mean number of PR mutations at baseline was 2.7, but it was higher in patients who subsequently failed DRV. In addition, the number of PR mutations increased at failure. The increase in the mean number of mutations was completely related to mutations considered to be associated with DRV resistance following the indications of the main DRV clinical trials. Discussion The higher statistical difference at baseline between failing versus non-failing patients was observed for the V32I and I84V mutations. At DRV failure, the major increase was still observed for V32I; I54L, V11I, T74P and I50V also increased. Despite the increment in the mean number of mutations per patient between baseline and failure, in 21 patients (17.8%) at baseline and 36 (30.5%) at failure, no PR mutation was detected. Conclusion: The HIV-DB interpretation algorithm identified few patients with full DRV resistance at baseline and few patients developed full resistance at DRV failure, indicating that complete resistance to DRV is uncommon. © Springer-Verlag 2011.
- Published
- 2012
13. No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy
- Author
-
Gianotti, N1, Galli, L, Zazzi, M, Ghisetti, V, Bonora, S, Micheli, V, Meraviglia, P, Corsi, P, Bruzzone, B, Menzo, S, Di Giambenedetto, S, De Luca, A, Filice, G, Penco, G, Castagna, A, Collaborators Giacometti A, ARCA database i. n. i. t. i. a. t. i. v. e., Butini, L, del Gobbo, R, Tacconi, D, Corbelli, G, Zanussi, S, Monno, L, Punzi, G, Maggiolo, F, Callegaro, A, Calza, L, Re, Mc, Pristerà, R, Turconi, P, Mandas, A, Tini, S, Carnevale, G, Paolini, E, Amadio, G, Sighinolfi, L, Zuccati, G, Morfini, M, Manetti, R, Di Pietro, M, Bartalesi, F, Colao, G, Tosti, A, Di Biagio, A, Setti, M, Trezzi, M, Orani, A, Pardelli, R, De Gennaro, M, Chiodera, A, Scalzini, A, Palvarini, L, Almi, P, Todaro, G, Gianotti, N, Cicconi, P, Rusconi, S, Gismondo, Mr, Biondi, Ml, Capetti, A, Boeri, E, Pecorari, M, Mussini, C, Santirocchi, M, Brustia, D, Ravanini, P, Dal Bello, F, Romano, N, Mancuso, S, Calzetti, C, Maserati, R, Baldanti, F, Francisci, D, Parruti, G, Polilli, E, Sacchini, D, Martinelli, C, Consolini, R, Vatteroni, L, Vivarelli, A, Nerli, A, Lenzi, L, Magnani, G, Ortolani, P, Andreoni, M, Palamara, G, Fimiani, C, Palmisano, L, Antinori, A, Vullo, Vincenzo, Turriziani, O, Perno, Cf, Montano, M, Cenderello, G, Gonnelli, A, Romano, L, Palumbo, M, Delle Foglie, P, Rossi, C, Poletti, F, Mondino, V, Malena, M, Lattuada, E., Gianotti, N, Galli, L, Zazzi, M, Ghisetti, V, Bonora, S, Micheli, V, Meraviglia, P, Corsi, P, Bruzzone, B, Menzo, S, Di Giambenedetto, S, De Luca, A, Filice, G, Penco, G, Castagna, A, Mancuso, S, Gianotti N, Galli L, Zazzi M, Ghisetti V, Bonora S, Micheli V, Meraviglia P, Corsi P, Bruzzone B, Menzo S, Di Giambenedetto S, De Luca A, Filice G, Penco G, Castagna A, Giacometti A, Butini L, del Gobbo R, Tacconi D, Corbelli G, Zanussi S, Monno L, Punzi G, Maggiolo F, Callegaro A, Calza L, Re MC, Pristerà R, Turconi P, Mandas A, Tini S, Carnevale G, Paolini E, Amadio G, Sighinolfi L, Zuccati G, Morfini M, Manetti R, Di Pietro M, Bartalesi F, Colao G, Tosti A, Di Biagio A, Setti M, Trezzi M, Orani A, Pardelli R, De Gennaro M, Chiodera A, Scalzini A, Palvarini L, Almi P, Todaro G, Cicconi P, Rusconi S, Gismondo MR, Biondi ML, Capetti A, Boeri E, Pecorari M, Mussini C, Santirocchi M, Brustia D, Ravanini P, Dal Bello F, Romano N, Mancuso S, Calzetti C, Maserati R, Baldanti F, Francisci D, Parruti G, Polilli E, Sacchini D, Martinelli C, Consolini R, Vatteroni L, Vivarelli A, Nerli A, Lenzi L, Magnani G, Ortolani P, Andreoni M, Palamara G, Fimiani C, Palmisano L, Antinori A, Vullo V, Turriziani O, Perno CF, Montano M, Cenderello G, Gonnelli A, Romano L, Palumbo M, Delle Foglie P, Rossi C, Poletti F, Mondino V, Malena M, Lattuada E., Gianotti, Nicola, Galli, Laura, Zazzi, Maurizio, Ghisetti, Valeria, Bonora, Stefano, Micheli, Valeria, Meraviglia, Paola, Corsi, Paola, Bruzzone, Bianca, Menzo, Stefano, Di Giambenedetto, Simona, De Luca, Andrea, Filice, Gaetano, Penco, Giovanni, and Castagna, Antonella
- Subjects
Male ,HIV Infections ,Drug resistance ,Logistic regression ,Resistance to nucleoside reverse transcriptase inhibitor ,CD4+ T-lymphocyte ,Retrospective Studie ,Immunopathology ,Antiretroviral Therapy, Highly Active ,Resistance to non-nucleoside reverse transcriptase inhibitor ,genetics ,Resistance to protease inhibitor ,HIV Infection ,resistance to nucleoside reverse transcriptase inhibitors ,Viral ,Sida ,resistance to protease inhibitors ,biology ,Reverse-transcriptase inhibitor ,Viral Load ,Genes, pol ,drug therapy/immunology/virology ,Reverse Transcriptase Inhibitor ,Infectious Diseases ,Treatment Outcome ,resistance to non-nucleoside reverse transcriptase inhibitors ,Reverse Transcriptase Inhibitors ,Female ,Viral load ,medicine.drug ,Human ,pol ,Anti-HIV Agents ,Antiretroviral Therapy ,Viremia ,Infectious Disease ,Settore MED/17 - MALATTIE INFETTIVE ,pharmacology/therapeutic use ,Acquired immunodeficiency syndrome (AIDS) ,Virology ,Drug Resistance, Viral ,medicine ,Humans ,Highly Active ,Retrospective Studies ,pharmacology/therapeutic use, Antiretroviral Therapy ,Highly Active, CD4 Lymphocyte Count, Drug Resistance ,genetics, Female, Genes ,pol, HIV Infections ,drug therapy/immunology/virology, HIV-1 ,drug effects/enzymology/genetics, Humans, Male, Mutation, Retrospective Studies, Reverse Transcriptase Inhibitors ,therapeutic use, Treatment Outcome, Viral Load ,drug resistance ,Anti-HIV Agent ,biology.organism_classification ,medicine.disease ,CD4 Lymphocyte Count ,Genes ,drug effects/enzymology/genetics ,therapeutic use ,Mutation ,CD4+ T-lymphocytes ,HIV-1 - Abstract
An investigation was undertaken to determine whether specific pol mutations hinder long-term immune recovery regardless of virological response. In total, 826 patients with >50 HIV RNA copies/ml, who underwent genotypic resistance testing between 1 January 2000 and 31 December 2003 after >3 years of antiretroviral treatment, and were followed up for >3 years after genotypic resistance testing, were analyzed retrospectively. The outcome of the study was the lack of immune recovery after >3 years of follow-up, defined as a slope by linear regression 50 copies/ml divided by the number of HIV RNA measurements during follow-up. Logistic regression was used for univariable and multivariable analysis. Median (Q1, Q3) values at baseline were the following: age 40 (37, 45) years, years on antiretroviral therapy 4.45 (3.65, 5.47), HIV RNA 3.91 (3.39, 4.53) log 10 copies/ml, CD4+ T-cell 358 (211, 524)/μl. After 3.13 years of follow-up, 375 patients (45.4%) showed a lack of immune recovery. The risk of lack of immune recovery increased independently with increasing baseline CD4+ counts (OR=1.104 per 50-cell increase, 95% CI=1.069-1.142, P
- Published
- 2011
14. Dengue surveillance using gravid oviposition sticky (GOS) trap and dengue non-structural 1 (NS1) antigen test in Malaysia: randomized controlled trial
- Author
-
Sivaneswari Selvarajoo, Jonathan Wee Kent Liew, Tock H. Chua, Wing Tan, Rafdzah Ahmad Zaki, Romano Ngui, Wan Yusoff Wan Sulaiman, Poo Soon Ong, and Indra Vythilingam
- Subjects
Medicine ,Science - Abstract
Abstract Dengue remains a major public threat and existing dengue control/surveillance programs lack sensitivity and proactivity. More efficient methods are needed. A cluster randomized controlled trial was conducted for 18 months to determine the efficacy of using a combination of gravid oviposition sticky (GOS) traps and dengue non-structural 1 (NS1) antigen for early surveillance of dengue among Aedes mosquito. Eight residential apartments were randomly assigned into intervention and control groups. GOS traps were placed at the intervention apartments weekly to trap Aedes mosquitoes and these tested for dengue NS1 antigen. When dengue-positive pool was detected, the community were notified and advised to execute protective measures. Fewer dengue cases were recorded in the intervention group than the control. Detection of NS1-positive mosquitoes was significantly associated with GOS Aedes index (rs = 0.68, P
- Published
- 2022
- Full Text
- View/download PDF
15. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis
- Author
-
Sergio Ferrazzani, Vanessa Marcon de Oliveira, Alfred K. Mbah, Romano N. Byaruhanga, Baskaran Thilaganathan, Miriam F. van Oostwaard, Doris M. Campbell, Lucy C Chappell, Ernesto Antonio Figueiró-Filho, Ingrid P.M. Gaugler-Senden, Francesca Chiaffarino, Jacob Alexander Lykke, Christopher W.G. Redman, Ewoud Schuit, Patrizia Vergani, Lucilla Poston, Wessel Ganzevoort, Fabio Facchinetti, Dimitri N.M. Papatsonis, Jun Zhang, Isabella Crippa, Sohinee Bhattacharya, Enrico Ferrazzi, Mark Brown, Eric A.P. Steegers, Camilla Haavaldsen, Raed Salim, Josje Langenveld, Ben W.J. Mol, Other departments, Obstetrics and Gynaecology, APH - Amsterdam Public Health, Obstetrics & Gynecology, Van Oostwaard, M, Langenveld, J, Schuit, E, Papatsonis, D, Brown, M, Byaruhanga, R, Bhattacharya, S, Campbell, D, Chappell, L, Chiaffarino, F, Crippa, I, Facchinetti, F, Ferrazzani, S, Ferrazzi, E, Figueiró Filho, E, Gaugler Senden, I, Haavaldsen, C, Lykke, J, Mbah, A, Oliveira, V, Poston, L, Redman, C, Salim, R, Thilaganathan, B, Vergani, P, Zhang, J, Steegers, E, Mol, B, and Ganzevoort, W
- Subjects
Gestational hypertension ,HELLP syndrome ,IPD ,gestational hypertension ,preeclampsia ,pregnancy ,recurrence ,Adult ,Anticonvulsants ,Antihypertensive Agents ,Chronic Disease ,Cohort Studies ,Female ,HELLP Syndrome ,Humans ,Hypertension ,Hypertension, Pregnancy-Induced ,Infant, Newborn ,Infant, Small for Gestational Age ,Postpartum Period ,Pre-Eclampsia ,Pregnancy ,Premature Birth ,Recurrence ,Severity of Illness Index ,Young Adult ,Medicine(all) ,Obstetrics ,Obstetrics and Gynecology ,Gestational age ,medicine.medical_specialty ,Hypertension in Pregnancy ,Pregnancy-Induced ,Preeclampsia ,medicine ,Journal Article ,Gynecology ,Eclampsia ,business.industry ,Infant ,Odds ratio ,medicine.disease ,Newborn ,Settore MED/40 - GINECOLOGIA E OSTETRICIA ,Small for Gestational Age ,business ,Meta-Analysis - Abstract
Objective We performed an individual participant data (IPD) metaanalysis to calculate the recurrence risk of hypertensive disorders of pregnancy (HDP) and recurrence of individual hypertensive syndromes. Study Design We performed an electronic literature search for cohort studies that reported on women experiencing HDP and who had a subsequent pregnancy. The principal investigators were contacted and informed of our study; we requested their original study data. The data were merged to form one combined database. The results will be presented as percentages with 95% confidence interval (CI) and odds ratios with 95% CI. Results Of 94 eligible cohort studies, we obtained IPD of 22 studies, including a total of 99,415 women. Pooled data of 64 studies that used published data (IPD where available) showed a recurrence rate of 18.1% (n = 152,213; 95% CI, 17.9–18.3%). In the 22 studies that are included in our IPD, the recurrence rate of a HDP was 20.7% (95% CI, 20.4–20.9%). Recurrence manifested as preeclampsia in 13.8% of the studies (95% CI,13.6–14.1%), gestational hypertension in 8.6% of the studies (95% CI, 8.4–8.8%) and hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome in 0.2% of the studies (95% CI, 0.16–0.25%). The delivery of a small-for-gestational-age child accompanied the recurrent HDP in 3.4% of the studies (95% CI, 3.2–3.6%). Concomitant HELLP syndrome or delivery of a small-for-gestational-age child increased the risk of recurrence of HDP. Recurrence increased with decreasing gestational age at delivery in the index pregnancy. If the HDP recurred, in general it was milder, regarding maximum diastolic blood pressure, proteinuria, the use of oral antihypertensive and anticonvulsive medication, the delivery of a small-for-gestational-age child, premature delivery, and perinatal death. Normotensive women experienced chronic hypertension after pregnancy more often after experiencing recurrence (odds ratio, 3.7; 95% CI, 2.3–6.1). Conclusion Among women that experience hypertension in pregnancy, the recurrence rate in a next pregnancy is relatively low, and the course of disease is milder for most women with recurrent disease. These reassuring data should be used for shared decision-making in women who consider a new pregnancy after a pregnancy that was complicated by hypertension.
- Published
- 2014
16. Cardiovascular events and intensity of treatment in polycythemia vera
- Author
-
Marchioli, R, Finazzi, G, Specchia, G, Cacciola, R, Cavazzina, R, Cilloni, D, De Stefano, V, Elli, E, Iurlo, A, Latagliata, R, Lunghi, F, Lunghi, M, Marfisi, Rm, Musto, P, Masciulli, A, Musolino, C, Cascavilla, N, Quarta, G, Randi, M. L., Rapezzi, D, Ruggeri, M, Rumi, E, Scortechini, Ar, Santini, S, Scarano, M, Siragusa, S, Spadea, A, Tieghi, A, Angelucci, E, Visani, G, Vannucchi, Am, Specchia G, Barbui T., D'Amico, A, Ferri, B, Guido, C, Marfisi, L, Pera, C, Polidoro, A, Sacco, M, Levantesi, G, Tognoni, G, Barosi, G, Carobbio, A, Leoni, P, Mulattieri, S, Tomassetti, S, Honorati, E, Ricco, A, Albano, F, Pastore, D, Carluccio, P, Mazzone, Am, Rossi, Ar, Finazzi, Mc, Delaini, F, Falanga, A, Rambaldi, A, Guaragna, G, Giannotta, A, Usala, E, Simula, Mp, Pilo, F, Cacciola, E, Pezzella, F, Seria, E, Di Francesco, E, Gallamini, A, Bertolotti, L, Antonioli, E, Guglielmelli, P, Pieri, L, Susini, Mc, Bartalucci, N, Bosi, A, D'Angelo, A, Centorrino, R, Gerace, D, Allegra, A, Cortelezzi, A, De Philippis, C, Ferretti, E, Ciceri, F, Claudiani, S, Malato, S, Trinca, S, Pogliani, Em, Belotti, A, Lanzi, E, Elli, Em, Gaidano, G, Deambrogi, C, Rossi, D, Saglio, G, Rotolo, A, Zanone, C, Bertozzi, I, Tezza, F, Aneloni, V, Quintini, G, Saccullo, G, Caracciolo, C, Cazzola, M, Casetti, I, Elena, C, Landini, B, Barulli, S, Guiducci, B, Lucesole, M, Malerba, L, Isidori, A, Grossi, A, De Stefanis, M, Biagioni, C, Merli, F, Imovilli, A, Codeluppi, K, Rubagotti, S, Romano, N, Bonini, A, Bellesia, E, Martorelli, Mc, Villani, O, Zifarone, E, Zonno, A, Santopietro, V, Za, T, Rossi, E, Ciminello, Am, Betti, S, Alimena, G, Tafuri, A, Breccia, M, Carmosino, I, Pisani, F, Romano, A, D'Andrea, M, Nobile, M, Mantuano, Fs, Rossi, G, Tricarico, M, Rodeghiero, F, Bedin, F, Lissandrini, L, Finotto, S., Marchioli, R, Finazzi, G, Specchia, G, Cacciola, R, Cavazzina, R, Cilloni, D, De Stefano, V, Elli, E, Iurlo, A, Latagliata, R, Lunghi, F, Lunghi, M, Marfisi, RM, Musto, P, Masciulli, A, Musolino, C, Cascavilla, N, Quarta, G, Randi, ML, Rapezzi, D, Ruggeri, M, Rumi, E, Scortechini, AR, Santini, S, Scarano, M, Siragusa, S, Spadea, A, Tieghi, A, Angelucci, E, Visani, G, Vannucchi, AM, Barbui, T, and CYTO-PV Collaborative Group.
- Subjects
Male ,Hematocrit ,RECURRENT THROMBOSIS ,law.invention ,Aged ,Antineoplastic Agents ,Cardiovascular Diseases ,Combined Modality Therapy ,Female ,Follow-Up Studies ,Humans ,Hydroxyurea ,Janus Kinase 2 ,Middle Aged ,Polycythemia Vera ,Thrombosis ,Phlebotomy ,Medicine (all) ,LEUKOCYTOSIS ,Polycythemia vera ,Randomized controlled trial ,law ,hemic and lymphatic diseases ,ESSENTIAL THROMBOCYTHEMIA ,Clinical endpoint ,Polycythemia Vera, Secondary Prophylaxis ,ESSENTIAL THROMBOCYTHEMIA, RECURRENT THROMBOSIS, RISK-FACTOR, HEMATOCRIT, MANAGEMENT, LEUKOCYTOSIS, PREVENTION, DIAGNOSIS, EFFICACY, WARFARIN ,medicine.diagnostic_test ,Hazard ratio ,General Medicine ,medicine.medical_specialty ,randomized trial ,polycythemia vera ,Cardiovascular event ,DIAGNOSIS ,WARFARIN ,RISK-FACTOR ,Internal medicine ,MANAGEMENT ,medicine ,Myelofibrosis ,Adverse effect ,business.industry ,EFFICACY ,medicine.disease ,PREVENTION ,Surgery ,Polycythemia Vera, Cardiovascular event, hematocrit ,Settore MED/15 - MALATTIE DEL SANGUE ,business - Abstract
A b s t r ac t Background Current treatment recommendations for patients with polycythemia vera call for maintaining a hematocrit of less than 45%, but this therapeutic strategy has not been tested in a randomized clinical trial. Methods We randomly assigned 365 adults with JAK2-positive polycythemia vera who were being treated with phlebotomy, hydroxyurea, or both to receive either more intensive treatment (target hematocrit
- Published
- 2013
17. Natural Human Infections with Plasmodium cynomolgi, P. inui, and 4 other Simian Malaria Parasites, Malaysia
- Author
-
Nan Jiun Yap, Hanisah Hossain, Thamayanthi Nada-Raja, Romano Ngui, Azdayanti Muslim, Boon-Peng Hoh, Loke Tim Khaw, Khamisah Abdul Kadir, Paul Cliff Simon Divis, Indra Vythilingam, Balbir Singh, and Yvonne Ai-Lian Lim
- Subjects
Plasmodium ,simian ,malaria ,zoonoses ,parasites ,Malaysia ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
We detected the simian malaria parasites Plasmodium knowlesi, P. cynomolgi, P. inui, P. coatneyi, P. inui–like, and P. simiovale among forest fringe–living indigenous communities from various locations in Malaysia. Our findings underscore the importance of using molecular tools to identify newly emergent malaria parasites in humans.
- Published
- 2021
- Full Text
- View/download PDF
18. Innovative vaccination protocol against vibriosis in Dicentrarchus labrax (L.) juveniles: Improvement of immune parameters and protection to challenge
- Author
-
Galeotti, M., Romano, N., Volpatti, D., Bulfon, C., Pascotto, E., Brunetti, A., Tiscar, P. G., Mosca, F., Bertoni, Fabrizio, Marchetti, Maria Gabriella, and Abelli, Luigi
- Subjects
European sea bass ,Immunity ,Listonella anguillarum ,Lymphocytes ,Vaccine ,Spleen ,complex mixtures ,Fish Diseases ,Immune system ,Immersion ,medicine ,Animals ,Sea bass ,General Veterinary ,General Immunology and Microbiology ,biology ,Vaccination ,Public Health, Environmental and Occupational Health ,biology.organism_classification ,Head Kidney ,Antibodies, Bacterial ,Respiratory burst ,Infectious Diseases ,medicine.anatomical_structure ,Immunoglobulin M ,Immunology ,Bacterial Vaccines ,Molecular Medicine ,Dicentrarchus ,Bass ,Gram-Negative Bacterial Infections ,Injections, Intraperitoneal ,Listonella - Abstract
The effect of vaccination on immune parameters of European sea bass, Dicentrarchus labrax, is not fully established, as well as surveyed throughout rearing till the commercial size. Furthermore, available information on the possible role of booster treatments is scarce. Sea bass juveniles were vaccinated against Listonella anguillarum using a commercial bivalent formulation administered by immersion (priming: 95 dph; booster: 165 dph) or by immersion (priming: 95 dph; booster: 165 dph) and subsequent i.p. injection (booster: 233 dph). Serum specific IgM and numbers of IgM+ cells in head kidney and spleen evidenced B-cell responses mainly after the immersion booster, accompanied by increased TcR-β transcripts and leucocyte respiratory burst. Immune enhancement was confirmed by the protection towards i.p. challenges with a virulent strain. RPS accounted for >70% in fish immersion-boosted and near 100% in fish further boosted i.p. Differently from usual farm practices, this innovative vaccination protocol proved to be highly effective. Booster treatments are therefore strongly recommended.
- Published
- 2012
19. Orang Asli Health and Lifeways Project (OA HeLP): a cross-sectional cohort study protocol
- Author
-
Ian J Wallace, Amanda J Lea, Yvonne A L Lim, Steven K W Chow, Izandis bin Mohd Sayed, Romano Ngui, Mohd Tajudin Haji Shaffee, Kee-Seong Ng, Colin Nicholas, Vivek V Venkataraman, and Thomas S Kraft
- Subjects
Medicine - Abstract
Introduction Non-communicable disease (NCD) risk is influenced by environmental factors that are highly variable worldwide, yet prior research has focused mainly on high-income countries where most people are exposed to relatively homogeneous and static environments. Understanding the scope and complexity of environmental influences on NCD risk around the globe requires more data from people living in diverse and changing environments. Our project will investigate the prevalence and environmental causes of NCDs among the indigenous peoples of Peninsular Malaysia, known collectively as the Orang Asli, who are currently undergoing varying degrees of lifestyle and sociocultural changes that are predicted to increase vulnerability to NCDs, particularly metabolic disorders and musculoskeletal degenerative diseases.Methods and analysis Biospecimen sampling and screening for a suite of NCDs (eg, cardiovascular disease, type II diabetes, osteoarthritis and osteoporosis), combined with detailed ethnographic work to assess key lifestyle and sociocultural variables (eg, diet, physical activity and wealth), will take place in Orang Asli communities spanning a gradient from remote, traditional villages to acculturated, market-integrated urban areas. Analyses will first test for relationships between environmental variables, NCD risk factors and NCD occurrence to investigate how environmental changes are affecting NCD susceptibility among the Orang Asli. Second, we will examine potential molecular and physiological mechanisms (eg, epigenetics and systemic inflammation) that mediate environmental effects on health. Third, we will identify intrinsic (eg, age and sex) and extrinsic (eg, early-life experiences) factors that predispose certain people to NCDs in the face of environmental change to better understand which Orang Asli are at greatest risk of NCDs.Ethics and dissemination Approval was obtained from multiple ethical review boards including the Malaysian Ministry of Health. This study follows established principles for ethical biomedical research among vulnerable indigenous communities, including fostering collaboration, building cultural competency, enhancing transparency, supporting capacity building and disseminating research findings.
- Published
- 2022
- Full Text
- View/download PDF
20. Low Rate of Virological Failure and Maintenance of Susceptibility to HIV-1 Protease Inhibitors with First-Line Lopinavir/Ritonavir-Based Antiretroviral Treatment in Clinical Practice
- Author
-
Prosperi, Mc, Zazzi, M, Punzi, G, Monno, L, Colao, G, Corsi, P, Di Giambenedetto, S, Meini, G, Ghisetti, V, Bonora, S, Pecorari, M, Gismondo, Mr, Bagnarelli, P, Carli, T, De Luca, A, ARCA Collaborative Group, Giacometti, A, Butini, L, del Gobbo, R, Menzo, S, Tacconi, D, Corbelli, G, Zanussi, S, Maggiolo, F, Callegaro, A, Calza, L, Re, Mc, Raffaele, P, Turconi, P, Mandas, A, Tini, S, Zoncada, A, Paolini, E, Amadio, G, Sighinolfi, L, Zuccati, G, Morfini, M, Manetti, R, Galli, L, Di Pietro, M, Bartalesi, F, Tosti, A, Di Biagio, A, Setti, M, Bruzzone, B, Penco, G, Trezzi, M, Orani, A, Pardelli, R, De Gennaro, M, Chiodera, A, Scalzini, A, Palvarini, L, Almi, P, Todaro, G, Monforte, A, Cicconi, P, Rusconi, S, Micheli, V, Biondi, Ml, Gianotti, N, Capetti, A, Meraviglia, P, Boeri, E, Mussini, C, Soria, A, Vecchi, L, Santirocchi, M, Brustia, D, Ravanini, P, Dal Bello, F, Romano, N, Mancuso, S, Calzetti, C, Maserati, R, Filice, G, Baldanti, F, Francisci, D, Parruti, G, Polilli, E, Sacchini, D, Martinelli, C, Consolini, Rita, Clinic of Infectious Diseases, Università cattolica del Sacro Cuore [Roma] (Unicatt), Molecular Biology, Microbiology and Virology, Bari University Hospital, Clinical Infectious Diseases, Careggi University Hospital, Unit of Infectious Diseases, Catholic Universisty of Sacred Heart, A. Savoia Hospital, infectiuos diseases, Università degli studi di Torino (UNITO), Modena University Hospital, L. Sacco University Hospital, Ancona University Hospital, Grosseto General Hospital, Institute of Infectious Diseases, Sacro Cuore Catholic University, Infectious Diseases Unit, University Hospital of Siena, Prosperi, M, Zazzi, M, Punzi, G, Monno, L, Colao, G, Corsi, P, Di Giambenedetto, S, Meini, G, Ghisetti, V, Bonora, S, Pecorari, M, Gismondo, M, Bagnarelli, P, Carli, T, De Luca, A, Mancuso, S, Prosperi MC, Zazzi M, Punzi G, Monno L, Colao G, Corsi P, Di Giambenedetto S, Meini G, Ghisetti V, Bonora S, Pecorari M, Gismondo MR, Bagnarelli P, Carli T, De Luca A, ARCA Collaborative Group [.., Giacometti A, Butini L, del Gobbo R, Menzo S, Tacconi D, Corbelli G, Zanussi S, Maggiolo F, Callegaro A, Calza L, Re MC, Raffaele P, Turconi P, Mandas A, Tini S, Zoncada A, Paolini E, Amadio G, Sighinolfi L, and ]
- Subjects
Male ,Lopinavir/ritonavir ,HIV Infections ,boosted protease inhibitor ,Lopinavir ,Cohort Studies ,0302 clinical medicine ,Antiretroviral Therapy, Highly Active ,virologic failure ,HIV Infection ,Treatment Failure ,030212 general & internal medicine ,Pyrimidinone ,0303 health sciences ,education.field_of_study ,lopinavir/ritonavir ,Viral Load ,Resistance mutation ,first-line antiretroviral therapy ,Reverse Transcriptase Inhibitor ,3. Good health ,Treatment Outcome ,Infectious Diseases ,RNA, Viral ,Reverse Transcriptase Inhibitors ,Medicine ,Drug Therapy, Combination ,Female ,Survival Analysi ,Viral load ,Human ,medicine.drug ,Anti-HIV Agents ,Population ,Pyrimidinones ,Settore MED/17 - MALATTIE INFETTIVE ,Emtricitabine ,human immunodeficiency virus type 1 ,03 medical and health sciences ,Virology ,Drug Resistance, Viral ,antiretroviral drug resistance ,medicine ,Humans ,Protease inhibitor (pharmacology) ,education ,HIV Protease Inhibitor ,Ritonavir ,030306 microbiology ,business.industry ,Anti-HIV Agent ,HIV Protease Inhibitors ,Survival Analysis ,HIV-1 ,Cohort Studie ,business - Abstract
Protease inhibitor (PI)-resistant HIV-1 has hardly ever been detected at failed boosted PI-based first-line antiretroviral regimens in clinical trials. However, this phenomenon has not been investigated in clinical practice. To address this gap, data from patients starting a first-line lopinavir/ritonavir (LPV/rtv)-based therapy with available baseline HIV-1 RNA load, a viral genotype and follow-up viral load after 3 and 6 months of treatment were extracted from the Italian Antiretroviral Resistance Cohort Analysis (ARCA) observational database. Based on survival analysis, 39 (7.1%) and 43 (7.8%) of the 548 examined patient cases had an HIV-1 RNA >500 and >50 copies/ml, respectively, after 6 months of treatment. Cox proportional hazard models detected baseline HIV-1 RNA (RH 1.79, 95%CI 1.10-2.92 per 1 - log10 increase, P = 0.02) and resistance to the nucleoside backbone (RH 1.04, 95%CI 1.02-1.06 per 10-point increase using the Stanford HIVdb algorithm, P < 0.001) as independent predictors of HIV-1 RNA at >500 copies/ml, but not at the >50 copies/ml cutoff criteria. Higher baseline viral load, older patient age, heterosexual route of infection and use of tenofovir/emtricitabine were predictors of failure at month 3 using the 50-copy and/or 500-copy threshold. Resistance to LPV/rtv did not occur or increase in any of the available 36 follow-up HIV-1 genotypes. Resistance to the nucleoside backbone (M184V) developed in four cases. Despite the likely differences in patient population and adherence, both the low rate of virological failure and the lack of development of LPV/rtv resistance documented in clinical trials are thus confirmed in clinical practice. J. Med. Virol. 82:1996-2003, 2010. © 2010 Wiley-Liss, Inc.
- Published
- 2010
- Full Text
- View/download PDF
21. Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting
- Author
-
Zazzi, M, Prosperi, M, Vicenti, I, Di Giambenedetto, S, Callegaro, A, Bruzzone, B, Baldanti, F, Gonnelli, A, Boeri, E, Paolini, E, Rusconi, S, Giacometti, A, Maggiolo, F, Menzo, S, De Luca, A, ARCA Collaborative Group, Butini, L, del Gobbo, R, Tacconi, D, Corbelli, G, Zanussi, S, Monno, L, Punzi, G, Calza, L, Re, Mc, Pristerà, R, Turconi, P, Mandas, A, Tini, S, Carnevale, G, Amadio, G, Sighinolfi, L, Zuccati, G, Morfini, M, Manetti, R, Corsi, P, Galli, L, Di Pietro, M, Bartalesi, F, Colao, G, Tosti, A, Di Biagio, A, Setti, M, Penco, G, Trezzi, M, Orani, A, Pardelli, R, De Gennaro, M, Chiodera, A, Scalzini, A, Palvarini, L, Almi, P, Todaro, G, Cicconi, P, Gismondo, Mr, Micheli, V, Biondi, Ml, Gianotti, N, Capetti, A, Meraviglia, P, Mussini, C, Pecorari, M, Santirocchi, M, Brustia, D, Ravanini, P, Dal Bello, F, Romano, N, Mancuso, S, Calzetti, C, Maserati, R, Filice, G, Francisci, D, Parruti, G, Polilli, E, Sacchini, D, Martinelli, C, Consolini, Rita, Zazzi, M, Prosperi, M, Vicenti, I, Di Giambenedetto, S, Callegaro, A, Bruzzone, B, Baldanti, F, Gonnelli, A, Boeri, E, Paolini, E, Rusconi, S, Giacometti, A, Maggiolo, F, Menzo, S, De Luca, A, Mancuso, S, Zazzi M, Prosperi M, Vicenti I, Di Giambenedetto S, Callegaro A, Bruzzone B, Baldanti F, Gonnelli A, Boeri E, Paolini E, Rusconi S, Giacometti A, Maggiolo F, Menzo S, De Luca A, ARCA Collaborative Group: [.., Butini L, del Gobbo R, Tacconi D, Corbelli G, Zanussi S, Monno L, Punzi G, Calza L, Re M C, Pristerà R, Turconi P, Mandas A, Tini S, and ]
- Subjects
Male ,interpretation system ,HIV Infections ,Drug resistance ,Logistic regression ,Retrospective Studie ,HIV Infection ,Pharmacology (medical) ,Microbial Sensitivity Test ,Middle Aged ,Prognosis ,genotype, drug resistance, algorithm ,Algorithm ,Treatment Outcome ,Infectious Diseases ,Italy ,RNA, Viral ,Female ,Cohort study ,Human ,Microbiology (medical) ,Adult ,medicine.medical_specialty ,Genotype ,Logistic Model ,Anti-HIV Agents ,Prognosi ,antiretroviral ,Microbial Sensitivity Tests ,Internal medicine ,medicine ,Potency ,Animals ,Humans ,Retrospective Studies ,Pharmacology ,Receiver operating characteristic ,business.industry ,Animal ,Anti-HIV Agent ,Retrospective cohort study ,Odds ratio ,genotype ,drug potency weighting ,Weighting ,Logistic Models ,ROC Curve ,Immunology ,HIV-1 ,business - Abstract
Objectives: To test retrospectively the ability of four freely available rules-based expert systems to predict short- and medium-term virological outcome following an antiretroviral treatment switch in pre-treated HIV-1 patients. Methods: The HIV-1 genotype interpretation systems (GISs) HIVdb, ANRS, Rega and AntiRetroScan were tested for their accuracy in predicting response to highly active antiretroviral therapy using 8 week (n = 765) and 24 week (n = 634) follow-up standardized treatment change episodes extracted from the Italian Antiretroviral Resistance Cohort Analysis (ARCA) database. A genotypic sensitivity score (GSS) was derived for each genotype-treatment pair for the different GISs and tested as a predictor of virological treatment outcome by univariable and multivariable logistic regression as well as by receiver operating characteristic curve analysis. The two systems implementing drug potency weights (AntiRetroScan and Rega) were evaluated with and without this correction factor. Results: All four GSSs were strong predictors of virological treatment outcome at both 8 and 24 weeks after adjusting for baseline viro-immunological parameters and previous drug exposure (odds ratios ranging from 2.04 to 2.43 per 1 unit GSS increase; P < 0.001 for all the systems). The accuracy of AntiRetroScan and Rega was significantly increased by drug potency weighting with respect to the unweighted versions (P ≤ 0.001). HIVdb and ANRS also increased their performance with the same drug potency weighting adopted by AntiRetroScan and Rega, respectively (P < 0.001 for both analyses). Conclusions: Currently available GISs are valuable tools for assisting antiretroviral treatment choices. Drug potency weighting can increase the accuracy of all systems. © The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
- Published
- 2009
22. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity
- Author
-
Brown, E. E., Fallin, D., Ruczinski, I., Hutchinson, A., Staats, B., Vitale, F., Lauria, C., Serraino, D., Rezza, G., Mbisa, G., Whitby, D., Messina, A., Goedert, J. J., Chanock, S. J., Romano, N., Ajello, F., Bonura, F., Perna, A. M., Viviano, E., Tramuto, F., Villafrate, M. R., Di Benedetto, M. A., Tamburini, M., Montella, M., Crispo, A., de Sicato, S., de Marco, M. R., Ascierto, P., Piselli, P., Valdarchi, C., Farchi, F., Corona, R. M., Di Carlo, A., Castilletti, C., Gafa, L., Stella, S., Massimino, M., Kroner, B., Chatterjee, N., Chen, J., Kiley, M., Chen, R., BROWN EE, FALLIN D, RUCZINSKI I, HUTCHINSON A, STAATS B, VITALE F, LAURIA C, SERRAINO D, REZZA G, MBISA G, WHITBY D, MESSINA A, GOEDERT JJ, CHANOCK SJ, KAPOSI SARCOMA WORKING GROUP, and Tramuto, F.
- Subjects
Adult ,Male ,Genotype ,Epidemiology ,Population ,Single-nucleotide polymorphism ,Biology ,Settore MED/42 - Igiene Generale E Applicata ,IL12A ,medicine ,Humans ,Genetic Predisposition to Disease ,Risk factor ,education ,Sarcoma, Kaposi ,Aged ,Aged, 80 and over ,education.field_of_study ,Classic Kaposi Sarcoma ,Polymorphism, Genetic ,Case-control study ,Cancer ,Herpesvirus Infection ,Odds ratio ,Middle Aged ,medicine.disease ,Oncology ,Haplotypes ,Italy ,Genetic Variant ,Case-Control Studies ,Immunology ,Herpesvirus 8, Human ,Cytokines ,Female - Abstract
Classic Kaposi sarcoma (CKS) is an inflammatory-mediated neoplasm primarily caused by Kaposi sarcoma–associated herpesvirus (KSHV). Kaposi sarcoma lesions are characterized, in part, by the presence of proinflammatory cytokines and growth factors thought to regulate KSHV replication and CKS pathogenesis. Using genomic DNA extracted from 133 CKS cases and 172 KSHV-latent nuclear antigen-positive, population-based controls in Italy without HIV infection, we examined the risk of CKS associated with 28 common genetic variants in 14 immune-modulating genes. Haplotypes were estimated for IL1A, IL1B, IL4, IL8, IL8RB, IL10, IL12A, IL13, and TNF. Compared with controls, CKS risk was decreased with 1235T/−1010G–containing diplotypes of IL8RB (odds ratio, 0.49; 95% confidence interval, 0.30-0.78; P = 0.003), whereas risk was increased with diplotypes of IL13 containing the promoter region variant 98A (rs20541, alias +130; odds ratio, 1.88; 95% confidence interval, 1.15-3.08; P = 0.01) when considered in multivariate analysis. Risk estimates did not substantially vary by age, sex, incident disease, or disease burden. Our data provide preliminary evidence for variants in immune-modulating genes that could influence the risk of CKS. Among KSHV-seropositive Italians, CKS risk was associated with diplotypes of IL8RB and IL13, supporting laboratory evidence of immune-mediated pathogenesis. (Cancer Epidemiol Biomarkers Prev 2006;15(5):926–34)
- Published
- 2006
23. Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma
- Author
-
Brown, E. E., Whitby, D., Vitale, F., Fei, P. C., Del Carpio, C., Marshall, V., Alberg, A. J., Serraino, D., Messina, A., Gafa, L., Goedert, J. J., Romano, N., Ajello, F., Bonura, F., Perna, A. M., Viviano, E., Tramuto, F., Villafrate, M. R., Di Benedetto, M. A., Tamburini, M., Montella, M., Crispo, A., De Sicato, S., De Marco, M. R., Ascierto, P., Piselli, P., Rezza, G., Valdarchi, C., Corona, R. M., Giuliani, M., Castilletti, C., Lauria, C., Laura, C., Stella, S., Massimino, M., Kroner, B., Biggar, R. J., Rabkin, C. S., BROWN EE, WHITBY D, VITALE F, CORDIALI FEI P, DEL CARPIO C, MARSHALL V, ALBERG AJ, SERRAINO D, MESSINA A, GAFA L, GOEDERT JJ, THE CLASSICAL KAPOSI SARCOMA WORKING GROUP, and Tramuto, F.
- Subjects
Male ,Epidemiology ,medicine.medical_treatment ,Comorbidity ,Settore MED/42 - Igiene Generale E Applicata ,medicine.disease_cause ,Kaposi sarcoma herpesvirus ,80 and over ,Leukocytes ,Gammaherpesvirinae ,Medicine ,HHV8 ,Viral ,Aged, 80 and over ,education.field_of_study ,biology ,virus diseases ,Immunosuppression ,General Medicine ,Herpesviridae Infections ,Middle Aged ,Viral Load ,Italy ,Herpesvirus 8, Human ,Female ,Antibody ,Kaposi sarcoma herpesviru ,Viral load ,Human ,Adult ,Viral DNA ,Population ,Mononuclear ,KSHV ,Peripheral blood mononuclear cell ,Herpesviridae ,Age Distribution ,Antigen ,Humans ,Herpesvirus 8 ,Sex Distribution ,education ,Aged ,business.industry ,Hemodynamics ,DNA ,biology.organism_classification ,Blood Cell Count ,Socioeconomic Factors ,Immunology ,DNA, Viral ,biology.protein ,Leukocytes, Mononuclear ,business - Abstract
Background: The presence of Human Herpesvirus-8 (HHV8) DNA is predictive of Kaposi sarcoma (KS) among patients with HIV-associated or iatrogenic immunosuppression. However, correlates of HHV8-DNA detection in the general population remain undefined. Methods: We assessed correlates of HHV8-DNA detection among Italian adults without KS who had antibodies against HHV8-latent nuclear antigen by immunofluorescence assay. HHV8-K6 DNA sequences were detected in peripheral blood mononuclear cells using TaqMan CR. Results: Of the 158 subjects 26 (16.5%) had detectable HHV8-DNA [median copies/million cells, 53; (13-2128)]. Adjusted for age, sex, and laboratory, HHV8-DNA was detected more frequently in participants with >7 total residents in the childhood home [OR = 3.7 (1.5-9.1)], >2 younger siblings [OR = 2.6 (1.1-6.5)], and current cardiovascular [OR = 3.6 (1.3-9.7)] or renal [OR = 3.1 (1.2-8.0)] disease. Excluding the participants using immune modulating drugs, HHV8-DNA was more frequent among those with low red blood cells (RBC) [92 μm3/red cell; OR = 2.8 (1.0-7.8)], and mild thrombocytopenia [
- Published
- 2005
24. A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen
- Author
-
PProsperi MC, Di Giambenedetto S, Fanti I, Meini G, Bruzzone B, Callegaro A, Penco G, Bagnarelli P, Micheli V, Paolini E, Di Biagio A, Ghisetti V, Di Pietro M, Zazzi M, De Luca A, Giacometti A, Butini L, del Gobbo R, Menzo S, Tacconi D, Corbelli G, Zanussi S, Monno L, Punzi G, Maggiolo F, CALZA, LEONARDO, RE, MARIA CARLA, Pristerà R, Turconi P, Mandas A, Tini S, Carnevale G, Amadio G, Sighinolfi L, Zuccati G, Morfini M, Manetti R, Galli L, Bartalesi F, Colao G, Tosti A, Setti M, Trezzi M, Orani A, Pardelli R, De Gennaro M, Chiodera A, Scalzini A, Palvarini L, Almi P, Todaro G, Gianotti N, Cicconi P, Rusconi S, Gismondo MR, Biondi ML, Capetti A, Meraviglia P, Boeri E, Pecorari M, Mussini C, Santirocchi M, Brustia D, Ravanini P, Dal Bello F, Romano N, Mancuso S, Calzetti C, Maserati R, Baldanti F, Francisci D, Parruti G, Polilli E, Sacchini D, Martinelli C, Consolini R, Vatteroni L, Vivarelli A, Nerli A, Lenzi L, Magnani G, Ortolani P, Andreoni M, Palamara G, Fimiani C, Palmisano L, Antinori A, Vullo V, Turriziani O, Perno CF, Montano M, Cenderello G, Gonnelli A, Romano L, Palumbo M, Bonora S, Delle Foglie P, Rossi C, Poletti F, Mondino V, Malena M, Lattuada E., PProsperi MC, Di Giambenedetto S, Fanti I, Meini G, Bruzzone B, Callegaro A, Penco G, Bagnarelli P, Micheli V, Paolini E, Di Biagio A, Ghisetti V, Di Pietro M, Zazzi M, De Luca A, Giacometti A, Butini L, del Gobbo R, Menzo S, Tacconi D, Corbelli G, Zanussi S, Monno L, Punzi G, Maggiolo F, Calza L, Re MC, Pristerà R, Turconi P, Mandas A, Tini S, Carnevale G, Amadio G, Sighinolfi L, Zuccati G, Morfini M, Manetti R, Galli L, Bartalesi F, Colao G, Tosti A, Setti M, Trezzi M, Orani A, Pardelli R, De Gennaro M, Chiodera A, Scalzini A, Palvarini L, Almi P, Todaro G, Gianotti N, Cicconi P, Rusconi S, Gismondo MR, Biondi ML, Capetti A, Meraviglia P, Boeri E, Pecorari M, Mussini C, Santirocchi M, Brustia D, Ravanini P, Dal Bello F, Romano N, Mancuso S, Calzetti C, Maserati R, Baldanti F, Francisci D, Parruti G, Polilli E, Sacchini D, Martinelli C, Consolini R, Vatteroni L, Vivarelli A, Nerli A, Lenzi L, Magnani G, Ortolani P, Andreoni M, Palamara G, Fimiani C, Palmisano L, Antinori A, Vullo V, Turriziani O, Perno CF, Montano M, Cenderello G, Gonnelli A, Romano L, Palumbo M, Bonora S, Delle Foglie P, Rossi C, Poletti F, Mondino V, Malena M, Lattuada E., Prosperi, M, Di Giambenedetto, S, Fanti, I, Meini, G, Bruzzone, B, Callegaro, A, Penco, G, Bagnarelli, P, Micheli, V, Paolini, E, Di Biagio, A, Ghisetti, V, Di Pietro, M, Zazzi, M, De Luca, A, and Mancuso, S
- Subjects
Oncology ,Male ,Adult ,Anti-HIV Agents ,Cohort Studies ,Drug Therapy, Combination ,Female ,HIV Infections ,HIV-1 ,Humans ,Middle Aged ,Proportional Hazards Models ,Treatment Failure ,Viral Load ,0302 clinical medicine ,ANTIRETROVIRAL THERAPY ,Medicine ,HIV Infection ,030212 general & internal medicine ,0303 health sciences ,Health Policy ,3. Good health ,Computer Science Applications ,Censoring (clinical trials) ,Cohort ,Combination ,lcsh:R858-859.7 ,Viral load ,Human ,Research Article ,Cart ,medicine.medical_specialty ,antiretroviral therapy ,Health Informatics ,Settore MED/17 - MALATTIE INFETTIVE ,lcsh:Computer applications to medicine. Medical informatics ,03 medical and health sciences ,Drug Therapy ,Internal medicine ,Survival analysis ,030306 microbiology ,business.industry ,Proportional hazards model ,ANTIRETROVIRAL DRUGS ,Anti-HIV Agent ,HIV ,GENOTYPES ,Discontinuation ,Regimen ,Immunology ,Proportional Hazards Model ,Cohort Studie ,business - Abstract
Background HIV-1 genotypic susceptibility scores (GSSs) were proven to be significant prognostic factors of fixed time-point virologic outcomes after combination antiretroviral therapy (cART) switch/initiation. However, their relative-hazard for the time to virologic failure has not been thoroughly investigated, and an expert system that is able to predict how long a new cART regimen will remain effective has never been designed. Methods We analyzed patients of the Italian ARCA cohort starting a new cART from 1999 onwards either after virologic failure or as treatment-naïve. The time to virologic failure was the endpoint, from the 90th day after treatment start, defined as the first HIV-1 RNA > 400 copies/ml, censoring at last available HIV-1 RNA before treatment discontinuation. We assessed the relative hazard/importance of GSSs according to distinct interpretation systems (Rega, ANRS and HIVdb) and other covariates by means of Cox regression and random survival forests (RSF). Prediction models were validated via the bootstrap and c-index measure. Results The dataset included 2337 regimens from 2182 patients, of which 733 were previously treatment-naïve. We observed 1067 virologic failures over 2820 persons-years. Multivariable analysis revealed that low GSSs of cART were independently associated with the hazard of a virologic failure, along with several other covariates. Evaluation of predictive performance yielded a modest ability of the Cox regression to predict the virologic endpoint (c-index≈0.70), while RSF showed a better performance (c-index≈0.73, p < 0.0001 vs. Cox regression). Variable importance according to RSF was concordant with the Cox hazards. Conclusions GSSs of cART and several other covariates were investigated using linear and non-linear survival analysis. RSF models are a promising approach for the development of a reliable system that predicts time to virologic failure better than Cox regression. Such models might represent a significant improvement over the current methods for monitoring and optimization of cART.
- Published
- 2011
- Full Text
- View/download PDF
25. Efficacy of triple dose albendazole treatment for soil-transmitted helminth infections.
- Author
-
Mian Zi Tee, Soo Ching Lee, Yi Xian Er, Nan Jiun Yap, Romano Ngui, Alice V Easton, Vinnie Wei Yin Siow, Kee Seong Ng, Christopher Chiong Meng Boey, Kek Heng Chua, Ken Cadwell, P'ng Loke, and Yvonne Ai Lian Lim
- Subjects
Medicine ,Science - Abstract
In Malaysia, soil-transmitted helminth (STH) infections still persist among indigenous communities. In the past, local studies have focused mostly on epidemiologic aspects of STH infections with a scarcity of information on the efficacy of deworming treatment. The present study consisted of 2 phases: a cross-sectional phase on current epidemiological status and risk factors of STH infections and a longitudinal study over 6 weeks on triple dose albendazole efficacy against STH infections. A total of 253 participants were recruited at baseline and a pre-tested questionnaire was administered to obtain information on socio-demographics, environmental and behavioural risk factors. Stool samples were evaluated using a modified Kato-Katz technique. Cure rate (CR) and egg reduction rate (ERR) were assessed at 3 weeks following a 3-day course of 400mg albendazole treatment and infection status were observed again at 6 weeks. Baseline positivity of trichuriasis, ascariasis and hookworm infections were 56.1%, 11.9% and 20.2%, respectively. Multivariate analysis showed age below 18 years old (P = 0.004), without latrine in house (P = 0.042) and indiscriminate defecation (P = 0.032) were associated with STH infections. In the longitudinal study (N = 89), CR for trichuriasis was 64.6%, while CR of 100% was observed for both ascariasis and hookworm. ERR was above 90% for all three STH species. A rapid increased of Trichuris trichiura egg output was observed at 6 weeks. In conclusion, STH infections are highly prevalent among indigenous communities. Children and teenagers, poor sanitation and hygiene behaviour were determinants for STH infections. Triple dose albendazole is found to be efficacious against Ascaris lumbricoides and hookworm infections but has moderate curative effect with high ERR against T. trichiura. Although triple dose albendazole regimen has logistic challenges and may not be a routine option, consideration of this treatment regime may still be necessary in selective communities to reduce high intensity of T. trichiura infection.
- Published
- 2022
- Full Text
- View/download PDF
26. Serum Rantes levels in HIV-positive individuals and in HIV-negative exposed health-care workers
- Author
-
Francesca Ajello, Romano N, F Bonura, Anna Maria Perna, and Francesco Vitale
- Subjects
Microbiology (medical) ,Chemokine ,Health Personnel ,HIV Infections ,Virus ,Acquired immunodeficiency syndrome (AIDS) ,Immunopathology ,Health care ,Medicine ,Humans ,Sida ,Chemokine CCL4 ,Chemokine CCL5 ,biology ,business.industry ,General Medicine ,Macrophage Inflammatory Proteins ,biology.organism_classification ,medicine.disease ,Infectious Diseases ,Lentivirus ,Immunology ,biology.protein ,HIV-1 ,Viral disease ,business - Published
- 1998
27. Neglected Intestinal Parasites, Malnutrition and Associated Key Factors: A Population Based Cross-Sectional Study among Indigenous Communities in Sarawak, Malaysia.
- Author
-
Yamuna Rajoo, Stephen Ambu, Yvonne Ai Lian Lim, Komalaveni Rajoo, Siew Chang Tey, Chan Woon Lu, and Romano Ngui
- Subjects
Medicine ,Science - Abstract
Intestinal parasitic infections (IPIs) have been recognized as one of the most significant causes of illness among disadvantaged communities. Many studies have been conducted on the prevalence of IPIs in Malaysia. However, these studies mostly focused on the indigenous groups in Peninsular Malaysia. The present study was conducted to provide the current baseline data on prevalence of IPIs, anaemia, malnutrition and associated risk factors among the indigenous communities in Sarawak, situation at northwest Borneo island of Malaysia. A cross sectional study was conducted among the longhouses communities. Stool samples were obtained and examined for the presence of IPIs using microscopy technique. Haemoglobin measurement was done using a portable haemoglobin analyzer. Malnutrition (i.e., stunting, underweight and wasting) was assessed using the WHO Anthro software. Statistical analysis was carried out using SPSS software. A total of 341participants took part in this study. The overall prevalence of IPIs was 57.5%. Multivariate analysis indicated that the absence of toilets (OR = 1.6; 95% CI = 1.1-2.7; p = 0.002) and close contact with animals (OR = 1.8; 95% CI = 1.3-2.9; p = 0.027) as significant predictors for IPIs. The incidence of anaemia was 36.4%. The incidence of underweight, wasting and stunting were 22.2%, 5.6% and 35.4%, respectively. Multivariate analysis demonstrated that low level of parental education attainment (OR = 1.9; 95% CI = 1.2-3.0; p = 0.006) was identified as significant predictor for anaemia. The incidence of wasting was significantly associated with mild anaemia (OR = 1.2; 95% CI = 0.9-1.7; p = 0.024). Low household income was identified as significant predictor for stunting (OR = 2.1; 95% CI = 9.8-22.2; p = 0.001) and underweight (OR = 1.9; 95% CI = 5.6-18.7; p = 0.037), respectively. Essentially, the present study highlighted that intestinal parasitic infections, anaemia and malnutrition are still prevalent among rural indigenous community in Sarawak. Improvement of socioeconomic status, periodic mass deworming, iron supplementation and health education program should be included in the control and prevention of public health strategies.
- Published
- 2017
- Full Text
- View/download PDF
28. A copula-based consistency analysis of education indicators
- Author
-
Cunha César, Fernández Mariela, García Jesús E., González-López Verónica Andrea, and Romano Nícolas
- Subjects
Conditional probability ,Asymmetric cubic sections copula ,Bayesian estimation ,Medicine ,Science - Abstract
In this paper we investigate the consistency of quality indicators of the Brazilian public educational system. According to the newspaper Estado de São Paulo – Brazil, of January 18, 2017, only 7.3% of students in the third year of high school have an adequate level of mathematics, this shows the relevance of the evaluation and assessment of the Brazilian educational system. In this paper we explore the dependence between two indicators: (i) mean value between the proportions (in two subjects: Portuguese and Mathematics) of students under the basic level (SARESP classification) and (ii) rate of fails, during the years 2013, 2014 and 2015. (i) and (ii) are bases to define the educational quality of public schools for the population of young people, between 14 and 17 years old. This inspection is carried out through the Bayesian estimation of the parameters of the Asymmetric Cubic Sections (ACS) copula. We show that the dependence profile, year after year, behaves in a very unstable way, although during those years there were no substantial changes which justify such instability. Through the copula we compute conditional probabilities of tail events. We verify that an inversion occurred in the concordance/discordance between (i) and (ii). We compute the probability of (i) assuming high values, conditioned to a threshold in (ii). In 2013, as the threshold in (ii) increases the probability increases (concordance), in 2014 the threshold in (ii) is almost irrelevant to the probability and in 2015, as the threshold in (ii) increases the probability decreases (discordance). The inspection of the tail dependence allows to expose some kind of manipulation, in view of for instance, the maintenance of a global index índice de desenvolvimento da educação de São Paulo (IDESP) used to classify the educational institutions.
- Published
- 2019
- Full Text
- View/download PDF
29. Tail conditional probabilities to predict academic performance
- Author
-
González-López Verónica Andrea, Piovesana Marina Capelari, and Romano Nícolas
- Subjects
Directional dependence ,Conditional probability ,Joe’s copula ,Bayesian estimation ,Medicine ,Science - Abstract
In this paper, we estimate tail conditional probabilities by incorporating copula models and adopting a Bayesian estimation process for the copula’s parameter. Based on the records of student’s classifications in (a) Mathematics and (b) Natural Sciences/Physics (of the entrance exam to the University of Campinas, from 2013 to 2015), by means of tail conditional probabilities we predict the performance, of the same students, in Calculus I which is a mandatory subject of the undergraduate course of Statistics, and we compare the conditional probabilities year after year. We see that (a), (b) and Calculus I show maximal trivariate correlations in tail events given by classifications which are jointly high/low in the three subjects. We compare the evolution of the tail conditional probabilities from 2013 to 2015 and, according to our results there has been an improvement (from 2013 to 2015) of at most 12%. This improvement being more incisive in the settings with conditional events given by jointly high classifications in comparison with settings with conditional events given by jointly lower classifications.
- Published
- 2019
- Full Text
- View/download PDF
30. Risk Factors for Enterovirus A71 Seropositivity in Rural Indigenous Populations in West Malaysia.
- Author
-
Nmn NikNadia, I-Ching Sam, Nasibah Khaidir, Romano Ngui, Yvonne A L Lim, Xiang Ting Goh, Seow Huey Choy, and Yoke Fun Chan
- Subjects
Medicine ,Science - Abstract
Enterovirus A71 (EV-A71), which is transmitted by the fecal-oral route, causes hand, foot and mouth disease and, rarely, severe neurological complications. In Malaysia, the indigenous rural community (Orang Asli) has a high prevalence of parasitic diseases due to poor sanitation, water supply and hygiene practices. This cross-sectional study compared the seroepidemiology of EV-A71 among rural Orang Asli and urban Kuala Lumpur populations in West Malaysia, and determined the risk factors associated with EV-A71 seropositivity in rural Orang Asli. Seropositive rates were determined by neutralization assay. EV-A71 seropositivity was strongly associated with increasing age in both populations. Rural Orang Asli children ≤12 years had significantly higher EV-A71 seropositivity rates than urban Kuala Lumpur children (95.5% vs 57.6%, P < 0.001), and also higher rates in the age groups of 1-3, 4-6 and 7-12 years. Multivariate analysis confirmed that age ≤12 years (adjusted OR 8.1, 95% CI 3.2-20.7, P < 0.001) and using untreated water (adjusted OR 6.2, 95% CI 2.3-16.6, P < 0.001) were independently associated with EV-A71 seropositivity in the Orang Asli population. Supply of clean drinking water may reduce the risk of EV-A71 infection. With significantly higher EV-A71 seropositive rates, younger rural children should be a priority target for future vaccination programs in Malaysia.
- Published
- 2016
- Full Text
- View/download PDF
31. Neglected tropical diseases among two indigenous subtribes in peninsular Malaysia: highlighting differences and co-infection of helminthiasis and sarcocystosis.
- Author
-
Soo Ching Lee, Romano Ngui, Tiong Kai Tan, Roslan Muhammad Aidil, and Yvonne Ai Lian Lim
- Subjects
Medicine ,Science - Abstract
Soil-transmitted helminth (STH) infections have been documented among these minority groups since 1938. However the prevalence of STH is still high among these communities. Most studies tend to consider the Orang Asli (indigenous) as a homogenous group. In contrary, different subtribes have their own cultural practices. To understand this variation better, we studied the prevalence and associated factors of STH and other gut parasitic infections among two common subtribes (i.e. Temuan and Temiar). Results showed that the prevalence of the overall STH infections was higher in the Temuan subtribe (53.2% of 171) compared to the Temiar subtribe (52.7% of 98). Trichuris trichiura (46.2%) was the most prevalent parasite in the Temuan subtribe, followed by Ascaris spp. (25.7%) and hookworm (4.1%). In contrast, Ascaris spp. (39.8%) was more prevalent among the Temiar subtribe, preceded by T. trichiura (35.7%) and finally hookworm (8.3%). There were also co-infections of helminthiasis and intestinal protozoa among both Temuan and Temiar subtribes with rates being three times higher among the Temiar compared to Temuan. The most common co-infection was with Entamoeba histolytica/dispar/moshkovskii (n = 24; 24.5%, 16.0-33.0), followed by Giardia spp. (n = 3; 3.1%, -0.3-6.5). In Temuan, STH infection individuals were also infected with Entamoeba histolytica/dispar/moshkovskii (n = 11; 6.4%, 5.0-13.8), Cryptosporidium spp. (n = 3, 1.8%, -0.2-3.8) and Giardia spp. (n = 2, 1.2%, -0.4-2.8). In comparison, there was no Cryptosporidium spp. detected among the Temiar. However, it was interesting to note that there was an occurrence of co-infection of intestinal helminthiasis and sarcocystosis (intestinal) in a Temiar individual. The last report of sarcocystosis (muscular) among the Orang Asli was in 1978. The present study highlighted the importance of understanding the variation of infections amongst the different Orang Asli subtribes. It is vital to note these differences and use this knowledge to customise effective control measures for the various subtribes.
- Published
- 2014
- Full Text
- View/download PDF
32. Rapid detection and identification of human hookworm infections through high resolution melting (HRM) analysis.
- Author
-
Romano Ngui, Yvonne A L Lim, and Kek Heng Chua
- Subjects
Medicine ,Science - Abstract
BackgroundHookworm infections are still endemic in low and middle income tropical countries with greater impact on the socioeconomic and public health of the bottom billion of the world's poorest people. In this study, a real-time polymerase chain reaction (PCR) coupled with high resolution melting-curve (HRM) analysis was evaluated for an accurate, rapid and sensitive tool for species identification focusing on the five human hookworm species.MethodsReal-time PCR coupled with HRM analysis targeting the second internal transcribed spacer (ITS-2) of nuclear ribosomal DNA as the genetic marker was used to identify and distinguish hookworm species in human samples. Unique and distinct characteristics of HRM patterns were produced for each of the five hookworm species. The melting curves were characterized by peaks of 79.24±0.05°C and 83.00±0.04°C for Necator americanus, 79.12±0.10°C for Ancylostoma duodenale, 79.40±0.10°C for Ancylostoma ceylanicum, 79.63±0.05°C for Ancylostoma caninum and 79.70±0.14°C for Ancylostoma braziliense. An evaluation of the method's sensitivity and specificity revealed that this assay was able to detect as low as 0.01 ng/µl hookworm DNA and amplification was only recorded for hookworm positive samples.ConclusionThe HRM assay developed in this study is a rapid and straightforward method for the diagnosis, identification and discrimination of five human hookworms. This assay is simple compared to other probe-based genotyping methods as it does not require multiplexing, DNA sequencing or post-PCR processing. Therefore, this method offers a new alternative for rapid detection of human hookworm species.
- Published
- 2012
- Full Text
- View/download PDF
33. Acute thrombosis of the superior mesenteric artery in a 39-year-old woman with protein-S deficiency: a case report
- Author
-
Luceretti Remo, Gentile Valerio, Lorenzetti Luca, Basili Giancarlo, Prosperi Valerio, Romano Nicola, Biondi Graziano, and Goletti Orlando
- Subjects
Medicine - Abstract
Abstract Introduction Acute thromboembolic occlusion of the superior mesenteric artery is a condition with an unfavorable prognosis. Treatment of this condition is focused on early diagnosis, surgical or intravascular restoration of blood flow to the ischemic intestine, surgical resection of the necrotic bowel and supportive intensive care. In this report, we describe a case of a 39-year-old woman who developed a small bowel infarct because of an acute thrombotic occlusion of the superior mesenteric artery, also involving the splenic artery. Case presentation A 39-year-old Caucasian woman presented with acute abdominal pain and signs of intestinal occlusion. The patient was given an abdominal computed tomography scan and ultrasonography in association with Doppler ultrasonography, highlighting a thrombosis of the celiac trunk, of the superior mesenteric artery, and of the splenic artery. She immediately underwent an explorative laparotomy, and revascularization was performed by thromboendarterectomy with a Fogarty catheter. In the following postoperative days, she was given a scheduled second and third look, evidencing necrotic jejunal and ileal handles. During all the surgical procedures, we performed intraoperative Doppler ultrasound of the superior mesenteric artery and celiac trunk to control the arterial flow without evidence of a new thrombosis. Conclusion Acute mesenteric ischemia is a rare abdominal emergency that is characterized by a high mortality rate. Generally, acute mesenteric ischemia is due to an impaired blood supply to the intestine caused by thromboembolic phenomena. These phenomena may be associated with a variety of congenital prothrombotic disorders. A prompt diagnosis is a prerequisite for successful treatment. The treatment of choice remains laparotomy and thromboendarterectomy, although some prefer an endovascular approach. A second-look laparotomy could be required to evaluate viable intestinal handles. Some authors support a laparoscopic second-look. The possibility of evaluating the arteriotomy, during a repeated laparotomy with a Doppler ultrasound, is crucial to show a new thrombosis. Although the prognosis of acute mesenteric ischemia due to an acute arterial mesenteric thrombosis remains poor, a prompt diagnosis, aggressive surgical treatment and supportive intensive care unit could improve the outcome for patients with this condition.
- Published
- 2011
- Full Text
- View/download PDF
34. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
- Author
-
Rivasi Paolo, Romano Nicola, Magistroni Riccardo, Leonelli Marco, Furci Luciana, Russi Gianpaolo, and Albertazzi Alberto
- Subjects
Medicine - Abstract
Abstract Introduction Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity. It is histologically characterized by a marked dilatation of the glomerular capillaries and the presence of lipoprotein thrombi in the glomerular lumens. The dyslipidemic profile is similar to that of type III dyslipoproteinemia with Apolipoprotein E values that are often high; proteinuria and renal dysfunction are present. Proteinuria often does not respond to steroid and cytostatic treatments. The phenotypic expression of lipoprotein glomerulopathy is most probably correlated to a genetic alteration of the lipoprotein metabolism (mutation of the Apolipoprotein E coding gene). In literature, lipoprotein glomerulopathies have mainly been reported in Japanese and Chinese subjects, except for three cases in the Caucasian race, reported in France and the USA. Case presentation We describe the case of a 60-year-old female, Caucasian patient suffering from lipoprotein glomerulopathy, carrier of a new mutation on the Apolipoprotein E gene (Apolipoprotein EMODENA), and treated successfully with low density lipoprotein-apheresis with the Heparin induced extracorporeal lipoprotein precipitation system. After a first phase of therapeutic protocol with statins, the patient was admitted for nephrotic syndrome, renal failure and hypertension. Since conventional treatment alone was not able to control dyslipidemia, aphaeretic treatment with heparin-induced Extracorporeal Lipoprotein Precipitation - apheresis (HELP-apheresis) was started to maintain angiotensin converting enzyme inhibitor therapy for the treatment of hypertension. Treatment with HELP-apheresis led to a complete remission of the proteinuria in a very short time (four months), as well as control of hypercholesterolemia and renal function recovery. Conclusion According to this case of lipoprotein glomerulopathy, we believe that renal damage expressed by proteinuria correlates to the levels of lipids and, furthermore, the treatment with HELP-apheresis, by lowering low-density lipoprotein cholesterol and triglycerides, may be considered as a therapeutic option in synergy with pharmacological treatment in the treatment of lipoprotein glomerulopathy.
- Published
- 2009
- Full Text
- View/download PDF
35. Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy
- Author
-
Lucia Sacchetti, Marcella Savoia, Nicola Romano, Vincenza Verde, Federica Zarrilli, Michele Rinaldi, Francesco Testa, Francesca Simonelli, Salvatore Mazzeo, Dino Franco Vitale, Simonelli, Francesca, Zarrilli, F, Mazzeo, S, Verde, V, Romano, N, Savoia, M, Testa, Francesco, Vitale, Df, Rinaldi, Michele, SACCHETTI L., RELATED ARTICLES, F., Simonelli, F., Zarrilli, S., Mazzeo, V., Verde, N., Romano, M., Savoia, F., Testa, D. F., Vitale, M., Rinaldi, Sacchetti, Lucia, Simonelli, F., Zarrilli, F., Mazzeo, S., Verde, V., Romano, N., Savoia, Marcella, Testa, F., Vitale, D. F., Rinaldi, M., and Sacchetti, L.
- Subjects
total plasma antioxidant capacity ,Male ,medicine.medical_specialty ,Aging ,Antioxidant ,reactive oxygen metabolites ,medicine.medical_treatment ,Clinical Biochemistry ,Physiology ,Biochemistry ,Antioxidants ,serum antioxidant ,chemistry.chemical_compound ,Macular Degeneration ,Risk Factors ,medicine ,Humans ,Carotenoid ,Life Style ,Aged ,chemistry.chemical_classification ,Chemistry ,Biochemistry (medical) ,oxidative status ,Retinol ,vitamin ,Age Factors ,General Medicine ,Macular degeneration ,Middle Aged ,medicine.disease ,Ascorbic acid ,vitamins ,Oxidants ,Surgery ,Diet ,Age-related maculopathy ,age-related maculopathy, oxidative status, vitamins, total plasma antioxidant capacity, reactive oxygen metabolites, Ox-LDL immunoglobulins ,age-related maculopathy ,Italy ,Ox-LDL immunoglobulins ,Maculopathy ,Female ,Disease Susceptibility ,Lipoprotein - Abstract
OBJECTIVES: The purpose of this study was to measure the oxidative and antioxidant biochemical parameters in the serum of Italian patients with age-related maculopathy (ARM) and in a similar age control group from the same area, in order to determine the weight of oxidative status as risk factor in the early stage of macular degeneration onwards. DESIGN AND METHODS: Forty-eight ARM patients (19 early and 29 late form) and 46 normal subjects, similar for age, sex and life-style, were studied. A series of serum and/or plasma antioxidants (vitamins C, E, A, total and individual carotenoids, zinc, total plasma antioxidant capacity--TRAP) and oxidative parameters (reactive oxygen metabolites--ROM, oxidized-low-density lipoprotein antibodies-anti-Ox-LDL) were evaluated in both groups, also with regard to age and disease stage. RESULTS: Levels of vitamins C, E, total carotenoids and beta-cryptoxanthine were lower in late ARM than in early ARM (p
- Published
- 2002
36. Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
- Author
-
Byaruhanga Romano N, Kizito Dennison, Mbidde Edward K, Banura Cecily, Hedman Klaus, Hedman Lea, Namujju Proscovia B, Muwanga Moses, Kirnbauer Reinhard, Surcel Heljä-Marja, and Lehtinen Matti
- Subjects
antibody ,avidity ,genital infection ,HPV ,prevalence ,Medicine ,Biology (General) ,QH301-705.5 ,Science (General) ,Q1-390 - Abstract
Abstract Background Low avidity of antibodies against viral, bacterial and parasitic agents has been used for differential diagnosis of acute versus recent/past infections. The low-avidity antibodies may however, persist for a longer period in some individuals. Findings We studied the association of human papillomavirus (HPV) type 16 antibody avidity with seroprevalence to HPV types 6/11/18/31/33/45. Antibody avidity was analysed for 365 HPV16 seropositive pregnant Finnish and Ugandan women using a modified ELISA. Low avidity of HPV16 antibodies was found in 15% of Finnish and 26% of Ugandan women. Ugandan women with low-avidity HPV16 antibodies had an increased risk estimate for HPV6/11 (odds ratio, OR 2.9; 95%CI 1.01-8.4) seropositivity but not to high-risk HPV types 18/31/33/45. Conclusion Association of the low avidity HPV16 antibody "phenotype" with possible susceptibility to infections with other HPV types warrants investigation.
- Published
- 2011
- Full Text
- View/download PDF
37. Defensive response of European sea bass (Dicentrarchus labrax) against Listonella anguillarum or Photobacterium damselae subsp. piscicida experimental infection
- Author
-
Enrico Volpe, Marco Galeotti, Donatella Volpatti, Marcella Massimini, Pietro Giorgio Tiscar, Francesco Mosca, Nicla Romano, Sara Ciulli, Chiara Bulfon, Elisabetta Caccia, Mosca F., Ciulli S., Volpatti D., Romano N., Volpe E., Bulfon C., Massimini M., Caccia E., Galeotti M., and Tiscar P. G.
- Subjects
Adaptive immunity ,Immunology ,Thymus Gland ,Real-Time Polymerase Chain Reaction ,Listonella anguillarum ,Microbiology ,Fish Diseases ,Random Allocation ,Hepcidins ,medicine ,Animals ,HSP70 Heat-Shock Proteins ,Acute response ,Sea bass ,General Veterinary ,biology ,Photobacterium ,Tumor Necrosis Factor-alpha ,Interleukins ,T-cell receptor ,Gene Expression Regulation, Bacterial ,Sea bassa ,Head Kidney ,Acquired immune system ,medicine.disease ,biology.organism_classification ,Immunohistochemistry ,Photobacterium damselae ,Humoral immunity ,RNA ,Bass ,Dicentrarchus ,Infection ,Gram-Negative Bacterial Infections ,Pasteurellosis ,Listonella ,Spleen - Abstract
Sea bass were experimentally infected with Listonella anguillarum or Photobacterium damselae subsp. piscicida (Phdp). At 24 and 72h post-infection, the expression analysis of immune-relevant genes (IL-1β, IL-6, IL-8, Hepcidin), the transcriptional level and detection of HSP70, and the quantification of serum iron were investigated in association with the histological analysis and the bacterial recognition in tissues by immunohistochemistry. At 15 days post-infection, the specific antibody response was detected in surviving fish, as well as the transcriptional levels of TcR and BcR sequences. Both experimental infections were characterized by a similar acute response, whereas different histological and immunohistochemistry evidences were observed. In particular, the early reaction appeared suitable for the clearance of L. anguillarum, thus limiting the histological lesions, the bacterial dissemination and the further development of acquired immunity in surviving fish. On the contrary, the innate response appeared not enough to resolve the Phdp infection, which was characterized by tissue damage, bacterial widespread and substantial detection of specific humoral immunity in surviving fish, also associated to lymphocytes clonal expansion. Besides the opportunistic conditions involved in fish vibriosis and pasteurellosis, the comparison between these experimental infection models seems to suggest that the rate of development of the acquired immunity is strictly linked to the activation of the host innate response combined to the degree of bacterial virulence.
- Published
- 2014
- Full Text
- View/download PDF
38. Tobacco use prevalence, knowledge and attitudes, and tobacco cessation training among medical students: results of a pilot study of Global Health Professions Students Survey (GHPSS) in Italy
- Author
-
Maria Rosaria Gualano, Giuseppe La Torre, Roberta Siliquini, Alberto Firenze, Walter Ricciardi, Fabrizio Bert, Nino Romano, Lamberto Manzoli, Antonio Boccia, Maria Sofia Cattaruzza, Davide Renzi, Gualano, MR, Siliquini, R, Manzoli, L, Firenze, A, Cattaruzza, MS, Bert, F, Renzi, D, Romano, N, Ricciardi, W, Boccia, A, and La Torre, G
- Subjects
medicine.medical_specialty ,tobacco use ,medical students ,smoking ,health professionals ,Tobacco use ,business.industry ,medicine.medical_treatment ,Public health ,Smoking ,education ,Tobacco control ,Public Health, Environmental and Occupational Health ,Socio-culturale ,Smoking, Tobacco use, Medical students, Health professionals ,Settore MED/42 - Igiene Generale E Applicata ,Logistic regression ,Medical students ,Family medicine ,Epidemiology ,Health care ,Global health ,medicine ,Health professionals ,Smoking cessation ,business - Abstract
Aim The aims of this study were to examine tobacco use prevalence, knowledge and attitudes, and tobacco cessation training among students attending Italian medical schools using the Global Health Professions Student Survey approach and to identify possible factors associated with smoking status. Subjects and Methods A multicentre cross-sectional pilot study was carried out in five Italian Schools of Medicine from March to April 2009. Questionnaires were administered in anonymous, voluntary and self-administered form to third year students attending medical schools. The outcome measure was “being a current smoker”. A logistic regression was used to evaluate possible factors associated with smoking status. Results The prevalence of current smokers was 31.4%. More than half considered health professionals as models for patients, and around 90% thought health professionals have a role in giving advice or information about smoking cessation. Only 5.8% of responders had received smoking cessation training during medical school. Medical students who considered healthcare professionals as behavioural models had lower likelihood of smoking (OR = 0.52). Conclusions Given the high prevalence of smokers among medical students and the poorness of smoking cessation programmes, it is important to create tobacco control training programmes addressed to healthcare students.
- Published
- 2011
- Full Text
- View/download PDF
39. Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy)
- Author
-
Nino Romano, Emanuele Amodio, Maria Grazia Laura Marsala, Alberto Firenze, Giovanna Anastasi, Maria Valeria Torregrossa, Amodio, E, Anastasi, G, Marsala, MGL, Torregrossa, MV, Romano, N, and Firenze, A
- Subjects
Adult ,Male ,Pandemic influenza vaccination, healthcare workers, adverse reactions ,Health Personnel ,education ,Orthomyxoviridae ,Settore MED/42 - Igiene Generale E Applicata ,medicine.disease_cause ,Teaching hospital ,Surveys and Questionnaires ,Environmental health ,Influenza, Human ,Health care ,Influenza A virus ,medicine ,Humans ,Hospitals, Teaching ,Adverse effect ,Sicily ,General Veterinary ,General Immunology and Microbiology ,biology ,business.industry ,Vaccination ,Public Health, Environmental and Occupational Health ,Pandemic influenza ,virus diseases ,Middle Aged ,biology.organism_classification ,Logistic Models ,Infectious Diseases ,Influenza Vaccines ,Multivariate Analysis ,Immunology ,Molecular Medicine ,Female ,Viral disease ,business - Abstract
The aim of the study was to investigate factors involved in vaccination acceptance among healthcare workers (HCWs) and adverse reactions rates associated with pandemic influenza vaccination. The study was carried out in the major teaching hospital of Sicily from November 2009 to February 2010 on 2267 HCWs. A total of 407 (18%) HCWs were vaccinated against the 2009 pandemic influenza A (H1N1). A logistic regression analysis indicates an increased risk of non-vaccination against pandemic influenza in females (OR = 1.6; 95% CI = 1.3-2.1) compared to males, in nurses/technicians/administrative workers (OR = 1.7; 95% CI = 1.3-2.2) compared to doctors/biologists, and in HCWs who were non-vaccinated against seasonal influenza in 2008-2009 (OR = 4.9; 95% CI = 3.7-6.5) compared to vaccinated HCWs. Overall, 302 (74.2%) out of 407 questionnaires distributed to vaccinated HCWs were returned within the observation period. One hundred fifty-two workers (50.3%) experienced at least one adverse reaction (30.1%, local reactions; 6.6% systemic reactions and 13.6% both of them). The most frequent side effect of vaccination was pain at the injection site (43.4%). Twelve (3.9%) out of 302 HCWs stated they experienced influenza-like illness episodes during the follow-up period. The use of an adjuvanted vaccine against pandemic influenza A (H1N1) appears to be an effective and safe preventive strategy, showing a prevalence of both local and systemic adverse reactions not very different from that seen after vaccination with non-adjuvanted seasonal influenza vaccine. Despite this finding, vaccination coverage among HCWs remains very low, suggesting the need to implement educational campaigns directed to groups with lower coverage rates
- Published
- 2011
- Full Text
- View/download PDF
40. Transmission of Drug-Resistant HIV Type 1 Strains in HAART-Naive Patients: A 5-Year Retrospective Study in Sicily, Italy
- Author
-
Filippa, Bonura, Fabio, Tramuto, Francesco, Vitale, Anna Maria, Perna, Enza, Viviano, Nino, Romano, R, Boncoraglio, Bonura, F, Tramuto, F, Vitale, F, Perna, AM, Viviano, E, and Romano, N
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Molecular Sequence Data ,Immunology ,HIV Infections ,Drug resistance ,Settore MED/42 - Igiene Generale E Applicata ,Virus ,Young Adult ,Antiretroviral Therapy, Highly Active ,Virology ,Molecular genetics ,Drug Resistance, Viral ,Genotype ,Prevalence ,medicine ,Humans ,Child ,Sicily ,Aged ,Retrospective Studies ,HAART-naive, HIV-1, drug resistance ,Protease ,Molecular epidemiology ,biology ,Infant ,virus diseases ,HIV Protease Inhibitors ,Middle Aged ,biology.organism_classification ,Reverse transcriptase ,Infectious Diseases ,Child, Preschool ,Mutation ,Lentivirus ,HIV-1 ,Reverse Transcriptase Inhibitors ,Female - Abstract
The transmission of drug-resistant HIV-1 strains might compromise the efficacy of current first-line antiretroviral (ARV) regimens. Between 2004 and 2008, HIV-1 reverse transcriptase (RT) and protease (PR) genes of 108 ARVnaive Sicilian patients were amplified and sequenced to describe the prevalence of ARV resistance mutations among HAART-naive HIV-1-infected individuals. The frequency of transmitted drug resistance mutations (DRAMs) was determined by using genotypic interpretation algorithms. The proportion of HAART-naive HIV- 1-infected patients in Sicily increased from 18.4% to 23.5% during 2004–2008. Among naive patients, the overall prevalence of DRAMs was 15.7% [17/108; 95% CI: 9.4–24.0]. DRAMs to nonnucleoside reverse transcriptase inhibitors (nNRTI) were detected most frequently [11/108 (10.2%)], of which K103N was the most prevalent (4.6%), whereas the prevalence of DRAMs was lowest for protease inhibitors (PI) [3/108 (2.8%)]. Drug resistance substitutions associated with two or three drug classes were rarely observed. The prevalence of HIV-1 DRAMs in Sicily was relatively higher than that observed in Italy and other European geographic areas and much higher than in resource-limited countries. However, the possible clinical role played by DRAMs in HAART-naive HIV- 1-infected individuals will require further assessment.
- Published
- 2010
- Full Text
- View/download PDF
41. Knowledge, attitudes and risk of HIV, HBV and HCV infections in hairdressers of Palermo city (South Italy)
- Author
-
Nino Romano, Emanuele Amodio, Carmelo Massimo Maida, Liborio Gennaro, Maria Antonella Di Benedetto, Amodio, E, Di Benedetto, MA, Gennaro, L, Maida, CM, and Romano, N
- Subjects
Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Population ,HIV Infections ,Settore MED/42 - Igiene Generale E Applicata ,medicine.disease_cause ,Occupational safety and health ,medicine ,Ultraviolet light ,Humans ,education ,Hepatitis ,Hepatitis B virus ,education.field_of_study ,business.industry ,Transmission (medicine) ,Public health ,Commerce ,Public Health, Environmental and Occupational Health ,Hepatitis C ,Hepatitis B ,medicine.disease ,Disinfection ,Italy ,Family medicine ,Immunology ,Equipment Contamination ,descriptive survey, hairdressers, KAP questionnaire ,business ,Hair - Abstract
Background: The hairdressing trade may potentially expose its practitioners and their customers to blood-borne infections. Methods: Knowledge, attitudes and behaviours towards occupational risk of HIV, HBV and HCV infections were evaluated in a cross-sectional survey, conducted during spring 2008, in 105 out of 112 randomly selected hairdressers of Palermo. Participants were queried by answering to an anonymous questionnaire. Results: Most of hairdressers (93.3%) knew that HIV and hepatitis are transmitted through parenteral route and could also be transmitted by razors. The availability of gloves was inadequate, up to 30% of the participants never used them and up to 50% usually reused them. In total, 90 respondents stated to perform a sterilization process of the cutting instruments by ultraviolet light, but only 70 sterilized the articles between two customers and only 34.3% executed a daily disinfection of the hair brushes. Statistical analysis showed that younger age and post-primary school instruction were significantly associated with knowledge and procedures that could prevent transmission of blood-borne virus ( P = 0.01 and P < 0.01, respectively). Moreover, only 32 hairdressers agreed to participate to a free specific course on occupational risk offered by the University of Palermo. Conclusion: Although the level of awareness among hairdressers about HIV, hepatitis and risk of transmission was good, there were some unsafe practices that may lead to infections due to blood-borne viruses. The present article highlights the need to improve specific health messages in media campaigns carried out to general population, diffusing more appropriate educational materials for salons and organizing obligatory refresher courses for the hairdressing sector.
- Published
- 2009
- Full Text
- View/download PDF
42. Immunization status of internationally adopted children in Italy
- Author
-
Rosalia Maria Valenti, Alberto Firenze, Enza Viviano, Salvatore Accomando, Francesco Cataldo, Nino Romano, Viviano, E, Cataldo, F, Accomando, S, Firenze, A, Valenti, RM, and Romano, N
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Health Status ,Tuberculin ,Antibodies, Viral ,Measles ,Rubella ,Medical Records ,Adoption ,medicine ,Humans ,Europe, Eastern ,Child ,Vaccines ,General Veterinary ,General Immunology and Microbiology ,Latent tuberculosis ,Tuberculin Test ,Tetanus ,business.industry ,Diphtheria ,Immunization ,Public Health, Environmental and Occupational Health ,Infant ,Emigration and Immigration ,Hepatitis B ,medicine.disease ,Antibodies, Bacterial ,Adopted children ,Infectious Diseases ,Italy ,Child, Preschool ,Immunology ,BCG Vaccine ,Molecular Medicine ,Female ,business - Abstract
An increasing number of internationally adopted children is coming to Italy, and their immunization status is unknown. We evaluated the immunization status of such children in Palermo, Italy. We searched for the presence of a BCG scar in 88 children, 49 boys and 39 girls (mean age 76+/-32 months), most of whom (98%) came from Eastern Europe. Presence of BCG scar was observed in 59 (67.1%) of them, included five children without any pre-adoptive medical records. Twenty-three out of 29 children without any evidence of BCG scar were tested by Mantoux. Seven (30.4%) of 23 were tuberculin positive and diagnosed as having latent tuberculosis infection. We also examined immunization status against poliovirus 1-3, tetanus, diphtheria, pertussis, measles, mumps, rubella and hepatitis B of 70 internationally adopted children and we compared it with the pre-adoptive immunization records of their birth country. Protective titers (>1:8) against poliovirus 1-3, were found respectively in 67.1%, 91.4%, 42.8% of 70 immunized children, and only 38.5% of them had at the same time full protection against all three types of poliovirus. Protective titers against tetanus and diphtheria were found in 91.4% and 95.7% of 70 vaccinated children. Presence of antibodies against pertussis, measles, mumps and rubella was observed respectively in 16 (32.6%) of 49, 40 (62.5%) of 64, 28 (56%) of 50 and 24 (85.7%) of 28 children who had received the vaccine. As regards hepatitis B, only 20 of 29 vaccinated children had detectable hepatitis B surface antibodies, while four of 29 vaccinated and two of 41 not vaccinated children were positive for both hepatitis B surface antibodies and hepatitis B core antibodies. Finally three of 41 not vaccinated children were both hepatitis B surface antigen and hepatitis B core antibodies positive. No relation was found between health status and immunization and between age and antibody positiveness of vaccinated children except for hepatitis B, therefore the youngest immunized children were more likely to be hepatitis B surface antibodies positive. Our data suggest that internationally adopted children should be tested for their immunization status on arrival in the adopting country, because they are not protected in a sufficient way against vaccine-preventable diseases and their pre-adoptive immunization records sometimes are lacking and frequently are scarcely reliable.
- Published
- 2006
- Full Text
- View/download PDF
43. Human papillomavirus is commonly present in psoriatic skin and normal skin samples from healthy subjects
- Author
-
Elisa Maria Martorana, Enza Viviano, Maria Colomba Migliore, Lucia Giovannelli, Valentina Caputo, Nino Romano, VIVIANO, E, GIOVANNELLI, L, MARTORANA, EM, MIGLIORE, MC, ROMANO, N, and CAPUTO, V
- Subjects
Adult ,Male ,medicine.medical_specialty ,business.industry ,Papillomavirus Infections ,Healthy subjects ,Dermatology ,Middle Aged ,Biochemistry ,Psoriatic skin ,Prevalence ,medicine ,Humans ,Psoriasis ,Female ,Human papillomavirus ,Normal skin ,business ,Molecular Biology ,Skin - Abstract
Letter to editor No abstract
- Published
- 2007
- Full Text
- View/download PDF
44. Evaluation of Fatty Acids in Membrane Phospholipids of Erythrocytes in Retinitis pigmentosa Patients
- Author
-
Giuseppe Nunziata, Ernesto Rinaldi, Olga Voto, Caterina Manna, Francesca Simonelli, Nicola Romano, Simonelli, Francesca, Manna, Caterina, Romano, N, Nunziata, G, Voto, O, and Rinaldi, E.
- Subjects
Adult ,Male ,Adolescent ,Docosahexaenoic Acids ,genetic structures ,Fundus Oculi ,Thin layer ,Biology ,Membrane Lipids ,Cellular and Molecular Neuroscience ,Retinitis pigmentosa ,Electroretinography ,medicine ,Humans ,Fluorescein Angiography ,Aged ,medicine.diagnostic_test ,Erythrocyte Membrane ,Fatty Acids ,General Medicine ,Middle Aged ,medicine.disease ,Fluorescein angiography ,Sensory Systems ,Ophthalmology ,Membrane ,Biochemistry ,Female ,Chromatography, Thin Layer ,Visual Fields ,Biomarkers ,Retinitis Pigmentosa - Abstract
Several investigators have observed abnormalities of plasma DHA in various common forms of retinitis pigmentosa. Erythrocyte membranes are an accessible tissue which may more closely reflect neural membrane fatty acid levels, but little data is yet available on their fatty acid composition in retinitis pigmentosa patients. We have evaluated the DHA levels in red blood cells membrane phospholipids in various genetic forms of retinitis pigmentosa and relative controls. The results obtained indicate significantly lower DHA levels in red blood cell membrane phospholipids in retinitis pigmentosa patients with respect to controls (p0.01). This data is significant for autosomal dominant forms only (p0.01). Fatty acid content alterations in membrane phospholipids of red blood cells may be considered as markers for abnormalities in the lipid metabolism which disturb the retina integrity.
- Published
- 1996
- Full Text
- View/download PDF
45. Infection with human herpes virus type 8 in an area at high prevalence for hepatitis C virus infection in southern Italy
- Author
-
Nino Romano, James J. Goedert, Anna Crispo, Maurizio Montella, M Fusco, Diego Serraino, MONTELLA M, SERRAINO D, CRISPO A, ROMANO N, FUSCO M, and GOEDERT JJ
- Subjects
Adult ,Male ,medicine.medical_specialty ,viruses ,Hepatitis C virus ,Population ,Antibodies, Viral ,medicine.disease_cause ,Seroepidemiologic Studies ,Virology ,Epidemiology ,Humans ,Medicine ,education ,Aged ,education.field_of_study ,High prevalence ,Hepatology ,business.industry ,Transmission (medicine) ,Human herpes virus ,Public health ,virus diseases ,Herpesviridae Infections ,Hepatitis C Antibodies ,Middle Aged ,medicine.disease ,Hepatitis C ,Cross-Sectional Studies ,Infectious Diseases ,Italy ,Hepatocellular carcinoma ,Herpesvirus 8, Human ,Female ,business - Abstract
Summary. The Campania Region is a geographical area of southern Italy characterized by high incidence rates of hepatocellular carcinoma and of classic Kaposi's sarcoma. Epidemiological investigations carried out among different population groups in this region have found high prevalence rates of both hepatitis C virus (HCV) and human herpesvirus type 8 (HHV-8). To assess co-infection rates of HCV and HHV-8, we carried out a cross-sectional seroepidemiological study prevalence in Pomigliano d'Arco, a Health District of Campania located 20 km away from Naples. The overall rate of HCV/HHV-8 co-infection was 3.1%, 3.5% among men and 2.7% among women. No difference emerged in the HCV/HHV-8 co-infection rates according to seropositivity for HCV infection, either overall (Mantel Haenszel odds ratio = 1.2, 95% CI: 0.6–2.6) or when the analysis was stratified by gender. These findings support the hypothesis that in Campania common routes of transmission are rarely shared by HCV and HHV-8 infections. Local factors may result in different epidemiological patterns for these two viral infections. However, our findings have important public health implications, especially in Mediterranean countries where HCV and HHV-8 infections are endemic.
- Published
- 2004
- Full Text
- View/download PDF
46. Immunoglobulin M seropositivity for Toscana virus in a random population sample in Sicily
- Author
-
Nino Romano, Giuseppe Calamusa, Francesco Vitale, Caterina Mammina, Gianni Gori-Savellini, James J. Goedert, Rosalia Maria Valenti, Emanuele Amodio, Maria Grazia Cusi, Melissa Valentini, Amodio, E, Cusi, MG, Valenti, RM, Valentini, M, Mammina, C, Gori-Savellini, G, Vitale, F, Romano, N, Goedert, JJ, and Calamusa, G
- Subjects
Microbiology (medical) ,Adult ,Male ,Adolescent ,Cross-sectional study ,Population ,Settore MED/42 - Igiene Generale E Applicata ,Antibodies, Viral ,Bunyaviridae Infections ,Article ,Young Adult ,Seroepidemiologic Studies ,Medicine ,Seroprevalence ,Humans ,Seroconversion ,education ,Child ,Sicily ,Aged ,Toscana virus ,Aged, 80 and over ,education.field_of_study ,biology ,business.industry ,Sandfly fever Naples virus ,General Medicine ,Middle Aged ,biology.organism_classification ,IgM seropositivity ,Infectious Diseases ,Cross-Sectional Studies ,Phlebovirus ,Immunoglobulin M ,Child, Preschool ,Immunoglobulin G ,Immunology ,biology.protein ,Female ,business ,Demography - Abstract
Summary Objectives High Toscana virus (TOSV) antibody seropositivity rates have been documented in the last decade, especially in the Mediterranean area. It is unclear if these rates are associated with a recent or past exposure to the virus. This is of importance, as primary infection can cause neurologic complications, especially in adults. The aim of the present study was to assess the current active TOSV circulation in western Sicily. Methods A cross-sectional seroprevalence study was conducted on 271 individuals aged 4–92 years, sampled from the general population of a small city. Each participant completed a self-administered questionnaire and provided serum, which was analyzed for the presence of specific anti-TOSV IgM and IgG. Results Anti-TOSV IgM was detected in eight (3.0%) participants, of whom only three had anti-TOSV IgG. The prevalence of anti-TOSV IgM was highest in subjects aged 25–34 and 35–44 years (7.1% and 4.8%, respectively). All subjects positive for anti-TOSV IgM were resident in the suburban area. Conclusions The detection of IgM documented the circulation of TOSV, a Phlebovirus, in a random population sample of Sicilian adults. The highest risk of TOSV seroconversion in subjects living in the suburbs appears to suggest a high density of TOSV vectors in peri-urban areas.
- Published
- 2012
47. Re-emergence of HIV Infection and Syphilis Among Men Who Have Sex with Men
- Author
-
Nino Romano, Maria Antonella Di Benedetto, Alberto Firenze, Jay Maddock, Di Benedetto, MA, Romano, N, and Firenze, A
- Subjects
Unprotected Sexual Intercourse ,Men who have sex with men (MSM) ,business.industry ,Transmission (medicine) ,Incidence (epidemiology) ,virus diseases ,HIV ,medicine.disease ,Settore MED/42 - Igiene Generale E Applicata ,Men who have sex with men ,Unsafe Sex ,Acquired immunodeficiency syndrome (AIDS) ,Syphili ,medicine ,Syphilis ,business ,Viral load ,Demography - Abstract
Sexual activity has been shown to be the primary mode of transmission for several important viral and bacterial infections among men who have sex with men (MSM) throughout the world and therefore sexually transmitted infections (STIs) are still one of major public health problem worldwide. Since the earliest days of the human immunodeficiency virus (HIV) epidemic MSM have been profoundly affected by the disease; by the time the first AIDS cases were reported in the early 1980s, HIV had already spread widely among homosexual and drug-user communities. In western Europe, has been estimated that HIV incidence peaked around 1983 among MSM and in 1987-88 among injecting drug users, with 120.000 homosexual/bisexual men infected by 1985, and 144.000 injecting drug users infected by 1989 (Downs et al., 2000). MSM account for a substantial proportion of HIV infections and compose a “bridging group” for transmission to heterosexuals because of the high frequency of reported bisexuality. Widescale behavioural modification in response to the emerging HIV/AIDS pandemic saw dramatic reductions in the incidence of many acute STIs in the late 1980s (WHO, 2007). However, these have not been maintained and many states are now observing increases in rates of diagnosed STIs; then the proportion of homosexual men reporting “unsafe sex”, often measured as unprotected anal intercourse (UAI) with casual partners, has increased since the mid-1990s (Prestage et al., 2005). In western Europe, among MSM, HIV diagnoses increased in 2002 (22%, from 2757 in 2001 to 3371 in 2002) after a slow decline in the previous years. Increased high risk sexual behaviour and migration of HIV-infected people from sub-Saharan Africa have contributed to the rise in the incidence of STIs since 2000 (Hamers & Downs, 2004). On the other hand, antiretroviral treatment, which lowers the viral load, may reduce the likelihood that an HIV infected person infect a partner during unprotected sexual intercourse. Mathematical modelling suggests that the effect of antiretroviral treatment on lowering transmission at the population level could be offset by an increase, even modest, in risk behaviour, and the net effect of these opposing forces on HIV incidence has been much debated (Katz et al., 2002).
- Published
- 2012
48. Seroprevalence of and risk factors for Toscana and Sicilian virus infection in a sample population of Sicily (Italy)
- Author
-
Caterina Mammina, Rosalia Maria Valenti, Gianni Gori-Savellini, Nino Romano, Giuseppe Calamusa, Maria Grazia Cusi, James J. Goedert, Francesco Vitale, Emanuele Amodio, Calamusa, G, Valenti, RM, Vitale, F, Mammina, C, Romano, N, Goedert, JJ, Gori-Savellini, G, Cusi, MG, and Amodio, E
- Subjects
Microbiology (medical) ,Adult ,Male ,Phlebovirus ,Adolescent ,Cross-sectional study ,Population ,Toscana viru ,Antibodies, Viral ,Article ,Young Adult ,Risk Factors ,Seroepidemiologic Studies ,Surveys and Questionnaires ,Seroprevalence ,Medicine ,Humans ,education ,Child ,Sicily ,Aged ,Aged, 80 and over ,education.field_of_study ,biology ,Transmission (medicine) ,Toscana virus ,business.industry ,Sandfly fever Naples virus ,Sicilian viru ,Middle Aged ,biology.organism_classification ,Infectious Diseases ,Cross-Sectional Studies ,Phlebotomus Fever ,Italy ,Child, Preschool ,Immunology ,Re-emergence ,Female ,Public Health ,business ,Demography - Abstract
Summary Objective The present study aimed to assess seroprevalence of and risk factors for Toscana (TOSV) and Sicilian (SFSV) virus infections in a sample of Sicilian subjects. Methods A cross-sectional seroepidemiological study was conducted on 271 individuals. Each participant completed a self-administrated questionnaire and provided a serum sample which was analyzed for the presence of IgG specific anti-TOSV and anti-SFSV viruses. Results Overall, 90 subjects (33.2%) were positive for TOSV IgG, 25 (9.2%) were positive for SFSV IgG and 11 (4%) were positive for both the viruses. A higher risk for TOSV seropositivity was found in participants who were older (adjOR = 1.02 per year; 95% CI = 1.01–1.03), having a pet living outdoors (adjOR = 2.62; 95% CI = 1.42–4.83) and being obese (adjOR = 2.37; 95% CI = 1.06–5.30). Conclusions TOSV seroprevalence appears to be relatively high in Sicilian general population, especially in older adults, representing a potential public health concern. The observations that seropositivity for TOSV was not significantly associated with SFSV seropositivity, and none of the risk factors associated with TOSV were associated with SFSV seem to suggest that these two phleboviruses may have different ecology and transmission pathways.
- Published
- 2011
49. Can technical, functional and structural characteristics of dental units predict Legionella pneumophila and Pseudomonas aeruginosa contamination?
- Author
-
Emanuele Amodio, L Aprea, Alberto Firenze, Nino Romano, Maria Stella Bivona, Lucia Cannova, Aprea,L, Cannova,L, Firenze,A, Bivona,MS, Amodio,E, and Romano,N
- Subjects
Air Microbiology ,Colony Count, Microbial ,Dental Facilities ,medicine.disease_cause ,Settore MED/42 - Igiene Generale E Applicata ,Legionella pneumophila ,Dental Equipment ,Risk Assessment ,Microbiology ,Teaching hospital ,Distribution system ,medicine ,Humans ,opportunistics pathogens, dental unit waterlines, risk assessment ,General Dentistry ,Respiratory Tract Infections ,Health Facility Size ,biology ,Pseudomonas aeruginosa ,business.industry ,Contamination ,biology.organism_classification ,Ventilation ,Occupational Diseases ,stomatognathic diseases ,Facility Design and Construction ,Equipment Contamination ,Water quality ,business ,Water Microbiology - Abstract
Legionella pneumophila and Pseudomonas aeruginosa are common colonizers of water environments, particularly dental unit waterlines. The aim of this study was to assess whether the technical, functional and structural characteristics of dental units can influence the presence and the levels of opportunistic pathogens. Overall, 42 water samples were collected from dental units in a teaching hospital in Palermo, Italy, including 21 samples from the 21 taps supplied by the municipal water distribution system and 21 samples from oral rinsing cups at 21 dental units. L. pneumophila was present in 16 out of 21 water samples (76.2%) from dental units, and the median concentration was higher in samples from oral rinsing cups than in those from taps (P < 0.001). P. aeruginosa was equally distributed in water samples collected from oral rinsing cups and from taps. Some characteristics of dental units (age, number of chairs per room, number of patients per day and water temperature) were slightly associated with the presence of P. aeruginosa, but not with contamination by L. pneumophila. Our experience suggests that L. pneumophila is frequently detected in dental units, as reported in previous studies, whereas P. aeruginosa is not a frequent contaminant. As a consequence, microbiological control of water quality should be routinely performed, and should include the detection of opportunistic pathogens when bacterial contamination is expected.
- Published
- 2011
50. MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients
- Author
-
Bennon Biryahwaho, Nino Romano, Elvio Alessi, Enza Viviano, Angelo Hatzakis, Franco M. Buonaguro, Edward Katongole-Mbidde, Vincenzo Ruocco, Luigi Buonaguro, Medea Cristillo, Maria Lina Tornesello, Marco Cusini, Robert Downing, Tornesello, Ml, Buonaguro, L, Cristillo, M, Biryahwaho, B, Downing, R, Hatzakis, A, Alessi, E, Cusini, M, Ruocco, Vincenzo, Viviano, E, Romano, N, KATONGOLE MBIDDE, E, and Buonaguro, Fm
- Subjects
Adult ,Cyclin-Dependent Kinase Inhibitor p21 ,Male ,Genotype ,Health, Toxicology and Mutagenesis ,Clinical Biochemistry ,Black People ,Biology ,Polymorphism, Single Nucleotide ,Biochemistry ,White People ,Young Adult ,Gene Frequency ,Risk Factors ,medicine ,Humans ,Genetic Predisposition to Disease ,Allele ,Young adult ,Sarcoma, Kaposi ,Kaposi's sarcoma ,Allele frequency ,Aged ,Aged, 80 and over ,Proto-Oncogene Proteins c-mdm2 ,Odds ratio ,Middle Aged ,medicine.disease ,Confidence interval ,Immunology ,Cancer research ,Female ,Sarcoma ,Tumor Suppressor Protein p53 - Abstract
A single-nucleotide polymorphism in the MDM2 promoter (SNP309; rs2279744) causes elevated transcription of this major negative regulator of p53 in several cancer types. We investigated MDM2 SNP309 and CDKN1A (p21/Waf1/Cip1) codon 31 (rs1801270) polymorphisms in 86 cases of cutaneous Kaposi's sarcoma (KS) from African and Caucasian patients, and 210 healthy controls. A significant increase of the MDM2 SNP309 T/G genotype was observed among classic KS cases (odds ratio 2.38, 95% confidence interval 1.0-5.5). Frequencies of CDKN1A codon 31 genotypes were not significantly different between cases and controls. The results suggest that the MDM2 SNP309 G allele may act as a susceptibility gene for the development of classic KS in Caucasian patients.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.